A61P

Therapeutic Activity

EPO Patent Bulletin

← All categories
Filter: All Correction Grant Limitation Publication Search Report

740 items

Publication

Selective Regulatory Gene (Srg) System For Genetically Modified Immune Cell Therapy

EP4502162A1 · Jichi Medical University · Mar 18, 2026
Publication

2 [(2 Oxo 4 Phenyl 2 H Chromen 7 Yl)oxy] Propanamido Derivatives

EP4499622A1 · Lunella Biotech, Inc. · Mar 18, 2026
Publication

Application Of Mulberry Extract In Preparation Of Drug For Treating Ulcerative Colitis

EP4501343A1 · Beijing Wehand-Bio Pharmaceutical Co., Ltd · Mar 18, 2026
Publication

Nlrp3 Inflammasome Inhibitors

EP4499646A1 · Hangzhou Highlightll Pharmaceutical Co., Ltd · Mar 18, 2026
Publication

Ptk7 Binding Protein And Use Thereof

EP4573129A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Indolizine Compounds For The Treatment Of Mental Disorders Or Inflammation

EP4499058A2 · Tactogen Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Cancer

EP4499625A1 · A2A Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Combination Nasal And Oral Therapy For Weight Loss

EP4499057A1 · Jackson, Milton S. · Mar 18, 2026
Publication

Inhibitors Of Interactions Between Trf1 Tin2 Or Trf2 Tin2 Telomeric Proteins For Use In Anticancer Therapy

EP4508048A1 · Politechnika Gdanska · Mar 18, 2026
Publication

Improved Thiopurine Formulation And Treatment Methods

EP4499105A1 · Douglas Pharmaceuticals Limited · Mar 18, 2026
Publication

Method For Producing Regulatory T Cells

EP4497822A1 · Kyoto University · Mar 18, 2026
Publication

Anti Her2/Anti Cd47 Molecules And Uses Thereof

EP4499711A1 · WuXi Biologics Ireland Limited · Mar 18, 2026
Publication

Anti Folate Receptor Alpha Antibodies And Methods Of Use

EP4499697A1 · Zymeworks BC Inc. · Mar 18, 2026
Publication

Polymeric Iron Binding Compositions And Methods Of Use For Treating Diseases Associated With Excess Damaging Reactive Iron

EP4499113A1 · FE PHARMACEUTICALS (CANADA) INC. · Mar 18, 2026
Publication

Velusetrag For Use In The Treatment Of Chronic Intestinal Pseudo Obstruction (Cipo)

EP4590303A1 · Alfasigma S.p.A. · Mar 18, 2026
Publication

Inhibitors Of Nlrp3

EP4630420A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

New Cyanopyridine Khk Inhibitor Compounds

EP4630114A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Bead Bound Anticd28 Antibody For The Treatment Of Malignant Melanoma

EP4630060A1 · Julius-Maximilians-Universität Würzburg · Mar 18, 2026
Publication

Crystalline Adipic Acid Salt Form Of A Ccr6 Antagonist

EP4630118A1 · Idorsia Pharmaceuticals Ltd · Mar 18, 2026
Publication

Binding Molecules Specific To Human Epidermal Growth Factor Receptor 2

EP4504796A1 · The National Institute for Biotechnology in the Negev Ltd. · Mar 18, 2026
Publication

Dimeric Compounds As Inhibitors Of Glycogen Synthase 1 (Gys1) And Methods Of Use Thereof

EP4587118A1 · Maze Therapeutics, Inc. · Mar 18, 2026
Publication

Abietanes And Methods Of Making And Using The Same

EP4499055A2 · The Florida State University Research Foundation, Incorporated · Mar 18, 2026
Publication

Methods And Compositions For Potentiation Of A Ligand

EP4499128A1 · Grinstaff, Mark W. · Mar 18, 2026
Publication

Therapeutic Agent For Respiratory Disease

EP4501326A1 · The Jikei University · Mar 18, 2026
Publication

Methods And Compositions For Modulating Kras(g12 D)

EP2024044334A2 · Ranok Therapeutics (Hangzhou) Co. Ltd. · Mar 18, 2026
Publication

Combinations And Pharmaceutical Compositions Comprising A Pi3 K/Akt/Mtor Pathway Inhibiting Compound

EP4587011A1 · Royal Holloway & Bedford New College · Mar 18, 2026
Publication

Organic Compounds

EP4493559A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Organic Compounds

EP4493560A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Nlrp3 Modulators

EP4493556A1 · Zomagen Biosciences Ltd · Mar 18, 2026
Publication

Blood Brain Barrier Crossing Mll1 Wdr5 Protein Protein Interaction Inhibitor Compounds And Uses Thereof

EP4493184A1 · Huyabio International, LLC · Mar 18, 2026
Publication

Composition For Controlling Proliferation Of Bacterium In Intestine, And Use Thereof

EP4494695A1 · MEIJI CO., LTD · Mar 18, 2026
Publication

Collinsella Bacteria Proliferation Controlling Composition And Use Thereof

EP4494484A1 · MEIJI CO., LTD · Mar 18, 2026
Publication

Composition For Controlling Proliferation Of Bacterium In Intestine, And Use Thereof

EP4494483A1 · MEIJI CO., LTD · Mar 18, 2026
Publication

Combination Of Multi Specific Molecule And Immune Checkpoint Inhibitor

EP4494655A1 · Daiichi Sankyo Company, Limited · Mar 18, 2026
Publication

Solid Composition Containing Formii Type Crystal Of Reduced Coenzyme Q10

EP4494637A1 · Kaneka Corporation · Mar 18, 2026
Publication

Depot Systems Comprising Cariprazine Or Salts Thereof

EP4493274A1 · Mapi Pharma Ltd. · Mar 18, 2026
Publication

Stable High Concentration Arginine Formulations Containing Pd 1 Antibody And Methods Of Use Thereof

EP4507726A1 · BeiGene Switzerland GmbH · Mar 18, 2026
Publication

Deuterated Heterocyclic Ketone Compound And Use Thereof

EP4509501A1 · Hinova Pharmaceuticals Inc. · Mar 18, 2026
Publication

Polycyclic Quinazolines For Inhibition Of Erbb2

EP4587124A1 · Enliven Inc. · Mar 18, 2026
Publication

3 (1 H Indole 2 Carbonyl) 6,6 Dimethyl N ((S) 1 Oxo 3 ((S) 2 Oxopyrrolidin 3 Yl)p Ropan 2 Yl) 3 Azabicyclo[3.1.0]Hexane 2 Carboxamide Derivatives As Mpro Inhibitors For The Treatment Of Coronavirus Infections

EP4587433A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Avian Influenza Vaccines And Methods Of Making Same

EP4504755A1 · The United States of America, as Represented by the Secretary of Agriculture · Mar 18, 2026
Publication

Lrrk2 Inhibitors

EP4504722A2 · Brenig Therapeutics, Inc. · Mar 18, 2026
Publication

Liquid Dispersible Halopyruvate Formulations And Associated Methods

EP4504152A2 · Ko, Young Hee · Mar 18, 2026
Publication

Lyophilized Perforated Placental Membrane Tissue Grafts

EP4504280A1 · MIMEDX Group Inc. · Mar 18, 2026
Publication

Combination Therapies Comprising A Sos1 Inhibitor And A Mek Inhibitor

EP4504197A2 · Mirati Therapeutics, Inc. · Mar 18, 2026
Publication

Combination Therapies Comprising A Sos1 Inhibitor And An Egfr Inhibitor

EP4504171A2 · Mirati Therapeutics, Inc. · Mar 18, 2026
Publication

Methods Of Selecting And Treating Cancer Subjects That Are Candidates For Treatment Using Inhibitors Of Parp

EP4496904A2 · Arima Genomics, Inc. · Mar 18, 2026
Publication

Salt Form And Crystal Form Of Vanin Enzyme Inhibitor, Method For Preparing Same, And Use Thereof

EP4495120A1 · Shanghai Meiyue Biotech Development Co., Ltd. · Mar 18, 2026
Publication

Claudin18.2 Humanized Antibody And Application Thereof

EP4495140A1 · Sunshine Lake Pharma Co., Ltd. · Mar 18, 2026
Publication

Pyrazole Membrane Associated Tyrosine And Threonine Specific Cdc2 Inhibitory Kinase (Pkmyt1) Inhibitors And Uses Thereof

EP4493557A1 · Insilico Medicine IP Limited · Mar 18, 2026
Publication

Pharmaceutical Composition Of Anti Tim 3 Antibody And Hypomethylating Agent

EP4494654A1 · Nanjing Shunxin Pharmaceuticals Co., Ltd. of Chiatai Tianqing Pharmaceutical Group · Mar 18, 2026
Publication

Multiplex Gene Edited Cells For Cd70 Directed Cancer Immunotherapy

EP4482872A2 · Nkarta, Inc. · Mar 18, 2026
Publication

Ophthalmic Formulations And Related Methods

EP4489783A1 · Eternatear, Inc. · Mar 18, 2026
Publication

Non Aromatic Cyclic Pyrimidine Analogs As Glucosylceramide Synthase Inhibitors

EP4490148A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Medication

EP4489751A1 · AFT Pharmaceuticals Limited · Mar 18, 2026
Publication

Composition For Preventing Or Treating Dental Caries

EP4491189A1 · Hysensbio Co., Ltd · Mar 18, 2026
Publication

Triazine Compound, Intermediate Thereof, Preparation Method Therefor And Use Thereof

EP4491623A1 · JKT Biopharma Co., Ltd. · Mar 18, 2026
Publication

Crystal Form Of Isochroman Compound

EP4491620A1 · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Mar 18, 2026
Publication

Pharmaceutical Composition, Adsorption Method, Treatment Method And Prevention Method

EP4491187A1 · Murata Manufacturing Co., Ltd. · Mar 18, 2026
Publication

Fap Inhibitors

EP4511367A1 · Shanghai Sinotau Biotech. Co., Ltd · Mar 18, 2026
Publication

Recombinant Aav Vectors For Treating Neurodegenerative Disorders

EP4511482A1 · Shanghai Vitalgen Biopharma Co., Ltd. · Mar 18, 2026
Publication

Inhibitors Of Kif18 A And Uses Thereof

EP4572855A1 · Accent Therapeutics, Inc. · Mar 18, 2026
Publication

Pharmaceutical Composition For Treatment Of Demyelinating Diseases Containing Supernatant Of Immortalized Mesenchymal Stem Cells, And Pharmaceutical Preparation Containing Same Composition As Active Ingredient

EP4487857A1 · Tokyo Medical University · Mar 18, 2026
Publication

Pharmaceutical Composition For Preventing And/Or Treating Autoimmune Diseases

EP4487843A1 · National Center for Child Health and Development · Mar 18, 2026
Publication

Regulatory T Cells With Chimeric Antigen Receptor Targeting Co Stimulatory Molecules To Prevent And/Or Treat Inflammatory Conditions

EP4486764A2 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Bioactives And Their Uses

EP4486354A1 · Arepa IP Limited · Mar 18, 2026
Publication

Injectable Formulation Comprising Isoxazoline Derivative And Method For Preparing Same

EP4467126A1 · LG Chem, Ltd. · Mar 18, 2026
Publication

Heterodimeric Polypeptide Complexes Comprising Il 15 Variants And Uses Thereof

EP4486795A1 · WuXi Biologics Ireland Limited · Mar 18, 2026
Publication

Proteolysis Targeting Influenza Virus, Method For Preparing Same And Use Thereof

EP2023160550A1 · Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences · Mar 18, 2026
Publication

Antibodies And Variants Thereof Against Human B7 H3

EP4482874A1 · Nanjing Probio Biotech Co., Ltd. · Mar 18, 2026
Publication

Combination Therapies For Treatment Of Cirrhosis With Portal Hypertension

EP4568673A1 · Astrazeneca AB · Mar 18, 2026
Publication

Adenosine Ligands For The Treatment Of Neurological Disorders

EP4479399A1 · Lucy Therapeutics, Inc. · Mar 18, 2026
Publication

2 Amino Pyrido[2,3 D]Pyrimidin 7(8 H) One And 7 Amino 1 Pyrimido[4,5 D]Pyrimidin 2(1 H) One Derivatives Derivatives As Egfr Inhibitors For The Treatment Of Cancer

EP4612148A1 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Use Of 5 (2 ((5 (4 (Dimethylamino)piperidin 1 Yl)pyridin 2 Yl)amino) 5 Fluoropyrimidin 4 Yl) N,4 Dimethylthiazol 2 Amine In Combination Therapies For Cancer

EP4493192A1 · Aucentra Therapeutics Pty Ltd · Mar 18, 2026
Publication

Virus Like Particles Displaying Sars Cov 2 Antigens As Booster Vaccines And Uses Thereof

EP4593874A2 · Bavarian Nordic A/S · Mar 18, 2026
Publication

Vectors Combining Anti Sickling Beta As3 Globin With Anti Bcel11 A Sh Rna Mir To Treat Beta Hemoglobinopathies

EP4490302A2 · The Regents of University of California · Mar 18, 2026
Publication

Systems And Methods For Genetic Modulation To Treat Ocular Diseases

EP4490295A1 · Epicrispr Biotechnologies, Inc. · Mar 18, 2026
Publication

Systems And Methods For Genetic Modulation To Treat Liver Disease

EP4490294A1 · Epicrispr Biotechnologies, Inc. · Mar 18, 2026
Publication

Compositions Comprising Hemp Extract And Related Treatment Methods

EP4489737A1 · Portland Technology Holdings LLC · Mar 18, 2026
Publication

Methods And Compositions For The Treatment Of Alcohol Toxicity

EP4489857A2 · The Board of Regents of the University of Texas System · Mar 18, 2026
Publication

Compositions And Methods For Cancer Immunotherapy

EP4475865A2 · Mural Oncology, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Modulating Gut Microbiomes

EP4475861A1 · The Regents Of The University Of Michigan · Mar 18, 2026
Publication

Multispecific Binding Agents And Uses Thereof

EP4475886A2 · Exelixis, Inc. · Mar 18, 2026
Publication

Peptide Binding To Mesothelin, And Use Thereof

EP4477660A1 · Kyungpook National University Industry-Academic Cooperation Foundation · Mar 18, 2026
Publication

Adjuvant Composition And Vaccine Composition

EP4470561A1 · Shin Nippon Biomedical Laboratories, Ltd. · Mar 18, 2026
Publication

Antigen Binding Protein And Use Thereof

EP4471064A1 · Minghui Pharmaceutical (Hangzhou) Limited · Mar 18, 2026
Publication

Uses And Methods For Promoting Increased Mitochondrial Mass And Function

EP4465976A1 · Brightseed, Inc. · Mar 18, 2026
Publication

Injectable Formulation Containing Isoxazoline Derivative

EP4458347A1 · LG Chem, Ltd. · Mar 18, 2026
Publication

Inhibitors Of Complement Factors And Uses Thereof

EP4463462A1 · Annexon, Inc. · Mar 18, 2026
Publication

Crystal Of Substituted Piperidine Compound, Salts Of Substituted Piperidine Compound, And Crystals Thereof

EP4438602A1 · Eisai R&D Management Co., Ltd. · Mar 18, 2026
Publication

Diaryl Compound As Tubulin/Src Dual Target Inhibitor

EP4464700A1 · Wuhan Humanwell Innovative Drug Research and Development Center Limited Company · Mar 18, 2026
Publication

Production Of Rna Polynucleotides Encoding Picornavirus

EP4514822A2 · ElevateBio Technologies, Inc. · Mar 18, 2026
Publication

Gd2 Chimeric Antigen Receptor And Use Thereof

EP4486790A1 · Beijing Meikang Geno-Immune Biotechnology Co., Ltd · Mar 18, 2026
Publication

Inhibitors Of Myeloperoxidase

EP4573096A1 · Astrazeneca AB · Mar 18, 2026
Publication

Prodrugs Of Stat3 Inhibitors

EP4539936A1 · Tvardi Therapeutics, Inc. · Mar 18, 2026
Publication

Hypoimmune Beta Cells Differentiated From Pluripotent Stem Cells And Related Uses And Methods

EP4463171A2 · Sana Biotechnology, Inc. · Mar 18, 2026
Publication

Modified Bacterium With Anti Tumour Activity

EP4464773A1 · Shenzhen Synthetica Pioneering Co., Ltd. · Mar 18, 2026
Publication

Steroid Compound, And Preparation Method Therefor And Use Thereof

EP4461736A1 · Shanghai Institute of Materia Medica, Chinese Academy of Sciences · Mar 18, 2026
Publication

Deuterated Organic Compounds And Uses Thereof

EP4460490A1 · Engrail Therapeutics, Inc. · Mar 18, 2026
Publication

Dosage Regimen For A Combination Therapy Consisting Oftcr Engineered T Cells In Combination With A Pd 1 Axis Binding Antagonist

EP4539874A1 · USWM CT, LLC · Mar 18, 2026
Publication

Spleen Tyrosine Kinase Inhibitors And Methods Of Use Thereof

EP4532469A1 · THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS · Mar 18, 2026
Publication

N Alkyl 2 Substituted Atp Analogues For Use As Antibacterial Agent

EP4536242A1 · Université de Liège · Mar 18, 2026
Publication

Autophagy Targeting Virus, And Preparation Method Therefor And Use Thereof

EP2023151630A1 · Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences · Mar 18, 2026
Publication

Novel Compositions For Reducing Methane Production In Ruminant Animals

EP4475827A1 · FutureFeed Pty Limited · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4472967A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Vaccine Against Leptospirosis

EP4469470A2 · Yale University · Mar 18, 2026
Publication

Compositions, Devices And Methods For Treating Cns Disorders

EP4469490A2 · Sigilon Therapeutics, Inc. · Mar 18, 2026
Publication

Use Of Myostatin Inhibitor For Treating Spinal Muscular Atrophy

EP4518970A2 · Scholar Rock, Inc. · Mar 18, 2026
Publication

Vectorized Anti Complement Antibodies And Complement Agents And Administration Thereof

EP4518972A2 · RegenxBio Inc. · Mar 18, 2026
Publication

Deuterated Domperidone For Treating Gastroparesis

EP4525868A1 · CinDome Pharma, Inc. · Mar 18, 2026
Publication

Novel Composition For Improvement Of Hair And Scalp Condition

EP4511051A1 · Lucas Meyer Cosmetics · Mar 18, 2026
Publication

Allogeneic T Cells For Treatment Of Hematological Malignancies

EP4511056A2 · Bluesphere Bio, Inc. · Mar 18, 2026
Publication

Extracellular Vesicle Depleted Blood Fractions

EP4504218A1 · Grifols Worldwide Operations Limited · Mar 18, 2026
Publication

Stabilized Nucleic Acid Compositions And Methods For Preparing, Storing And Using The Same

EP2024193827A1 · Mar 18, 2026
Publication

Composition Comprising Nicotinamide, Nicotinamide Precursors, Nicotinamide Metabolites Or Combinations Thereof For Preventing Or Reducing One Or More Post Acute Symptoms Of Infectious Diseases

EP4499059A1 · CONARIS Research Institute AG · Mar 18, 2026
Publication

Ionic Liquid Based Formulations For The Prevention Or Treatment Of Neurological Diseases

EP4469044A1 · Universidade de Aveiro · Mar 18, 2026
Publication

Methods Of Dispersing Aripiprazole Injectable Preparations

EP2024194955A1 · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486442A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

(4 Benzo[D]Oxazol 2 Yl) 6,7 Dihydro 1 H Imidazo[4,5 C]Pyridine 5(4 H) Yl)methanone Derivatives As Mutant Pah Stabilizers For The Treatment Of Phenylketonuria

EP4486744A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486447A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486749A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486446A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Anti Ed A Antibodies For The Treatment Of Pulmonary Hypertension

EP4493210A1 · Universitätsklinikum Jena · Mar 18, 2026
Publication

Stable Aqueous Formulation Of An Anti Adrenomedullin (Adm) Antibody Or Anti Adm Antibody Fragment

EP4493588A1 · AdrenoMed AG · Mar 18, 2026
Publication

Extracellular Vesicle Depleted Blood Fractions

EP4504219A1 · Grifols Worldwide Operations Limited · Mar 18, 2026
Publication

Solid Forms Of Ceftolozane

EP4327828A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Compounds And Combination As Stimulators Of Collagen Synthesis

EP4541351A1 · Center for Intelligent Research in Crystal Engineering, S.L. · Mar 18, 2026
Publication

Elvitegravir To Treat Multidrug Resistant Gram Positive Bacteria Infections

EP4541354A1 · Fundación Privada Instituto De Salud Global Barcelona · Mar 18, 2026
Publication

Anticonvulsant Activity Of Steroids

EP4335505A2 · The Regents of the University of California · Mar 18, 2026
Publication

Pharmaceutical Composition Containing A Surfactant And Natural Plant Extracts For Preventing And Treating Coronavirus

EP4299132A2 · Portillo Rosado, Rosa Maria · Mar 18, 2026
Publication

Variants Of The Human Atm Protein For The Treatment Of Diseases Related To At Least One Mutation Of The Atm Gene

EP4479527A1 · Quince Therapeutics, Inc. · Mar 18, 2026
Publication

Cgas Super Enzymes For Cancer Immunotherapy

EP4482500A1 · ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) · Mar 18, 2026
Publication

Soluble Endoglin For Use In Treating Or Preventing Thrombus Formation

EP4475870A1 · Institut National de la Santé et de la Recherche Médicale (INSERM) · Mar 18, 2026
Publication

Novel T Cell Receptor

EP4472742A1 · University College Cardiff Consultants Limited · Mar 18, 2026
Publication

Connexin 43 For Use In Treating Brca1/2 Mutated Cancer

EP4463162A1 · Fundación Profesor Novoa Santos · Mar 18, 2026
Publication

Use Of The Cd2 Signaling Domain In Second Generation Chimeric Antigen Receptors

EP4275699A2 · The Trustees of the University of Pennsylvania · Mar 18, 2026
Publication

Pharmaceutical Composition For Treating Muscle Atrophy Comprising Glucagon Like Peptide 1 Receptor Agonist

EP4272823A2 · Immunoforge Co., Ltd. · Mar 18, 2026
Publication

A Method For Morselizing And/Or Targeting Pharmaceutically Active Principles To Synovial Tissue

EP4374861A2 · MedinCell S.A. · Mar 18, 2026
Publication

Crystalline Forms Of N (4 (4 (Cyclopropylmethyl) Piperazine 1 Carbonyl)phenyl)quinoline 8 Sulfonamide

EP4285904A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Oral Rehydration Composition Comprising Lactose, Sodium Chloride, Sodium Bicarbonate, Glycine, Potassium And Zeolite And Its Use In Treating Gastrointestinal Disorders

EP4302758A1 · Farmacia del Corso Snc di Ferri Sonia & C. · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248967A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248966A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

A Pyrazole Pharmaceutical Composition

EP4282475A2 · Intervet International B.V. · Mar 18, 2026
Publication

Menotropin For Treating Infertility

EP4289477A2 · Ferring B.V. · Mar 18, 2026
Publication

Crystalline Forms Of (2 R,5 S,13 Ar) 8 Hydroxy 7,9 Dioxo N (2,4,6 Trifluorobenzyl) 2,3,4,5,7,9,13,13 A Octahydro 2,5 Methanopyrido [1',2':4,5]Pyrazino [2,1 B][1,3]Oxazepine 10 Carboxamide

EP4309736A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Formulations Of Guanylate Cyclase C Agonists And Methods Of Use

EP4309673A2 · Bausch Health Ireland Limited · Mar 18, 2026
Publication

Compound For Use In Methods For Treatment Of Polycystic Kidney Disease

EP4268891A2 · Regulus Therapeutics Inc. · Mar 18, 2026
Publication

New Delayed Release Composition For Peroral Administration

EP4218737A1 · Vicore Pharma AB · Mar 18, 2026
Publication

Peptide Having Effects Of Increasing Telomerase Activity And Extending Telomere, And Composition Containing Same

EP4272829A2 · Gemvax & Kael Co., Ltd. · Mar 18, 2026
Publication

Process For The Preparation Of Erythrocytes Loaded With One Or More Substances Of Pharmaceutical Interest And So Obtained Erythrocytes

EP4338803A2 · Quince Therapeutics, Inc. · Mar 18, 2026
Publication

Alkyl Chain Modified Imidazoquinoline Derivatives As Tlr7/8 Agonists And Uses Thereof

EP4257198A2 · Dynavax Technologies Corporation · Mar 18, 2026
Publication

Culture Medium For Epithelial Stem Cells And Organoids Comprising Said Stem Cells

EP4253529A2 · Koninklijke Nederlandse Akademie van Wetenschappen · Mar 18, 2026
Publication

Gip/Glp1 Agonist Compositions

EP4257185A2 · Eli Lilly and Company · Mar 18, 2026
Publication

Identification Of Common Tumor Specific T Cell Receptors And Antigens

EP4249592A2 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Topical Compositions And Methods For Treating Inflammatory Skin Diseases

EP4252844A2 · AZORA THERAPEUTICS, INC. · Mar 18, 2026
Publication

Low Concentration Atropine For Myopia Prevention (Lamp 2) Study

EP4311551A1 · The Chinese University of Hong Kong · Mar 18, 2026
Publication

Neuroactive Steroids, Compositions, And Uses Thereof

EP4245369A2 · Sage Therapeutics, Inc. · Mar 18, 2026
Publication

Product Comprising Probiotics And Isomaltulose And Method Of Its Production

EP4260864A1 · Bluestone Pharma GmbH · Mar 18, 2026
Publication

Superoxide Dismutase And Uses Thereof For Preventing Or Treating Diabetic Retinopathy Or Uveitis

EP4527405A1 · Genofocus, Inc. · Mar 18, 2026
Publication

Use Of Insulin Like Growth Factor Binding Protein 2 In Preparation Of Drug For Treating Neurodemyelinating Diseases

EP4356921A1 · Shanghai Mental Health Center (Shanghai Psychological Counselling Training Center) · Mar 18, 2026
Publication

Development Of Novel Pdl1 Single Domain Antibody

EP4458855A1 · Persongen Biotherapeutics (Suzhou) Co., Ltd. · Mar 18, 2026
Publication

Anti Coronavirus Polypeptide, And Derivatives Thereof And Application Thereof

EP4458844A1 · Institute Of Microbiology, Chinese Academy Of Sciences · Mar 18, 2026
Publication

Gene Therapy For Lamin A Associated Deficiencies

EP4453226A1 · The Trustees of the University of Pennsylvania · Mar 18, 2026
Publication

Compositions And Methods For Diagnosis, Treatment Of And Prevention Of Kidney Disease

EP4453235A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Pyrimidine Heterocyclic Compound, Preparation Method Therefor And Use Thereof In Medicine

EP4455132A1 · Insilico Medicine IP Limited · Mar 18, 2026
Publication

Substituted Fused Heterocyclic Compound, And Preparation Method Therefor And Use Thereof

EP4455144A1 · Shanghai Annova Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Use Of Conditioned Medium Of Cord Lining Mesenchymal Stem Cells For Healing And/Or Preventing The Formation And/Or Recurrence Of A Wound Or A Damaged Skin Area

EP4630022A1 · CellResearch Corporation Pte. Ltd. · Mar 18, 2026
Publication

Ophthalmic Formulation For Topical Use Containing Helenalin, 11 A,13 Dihydro Helenalin And Flavonoids From Arnica Montana Extract And Sodium Hyaluronate, And Use Thereof By Humans To Treat Dry Eye Syndrome

EP4631513A1 · Centro de Retina Médica Y Quirúrgica, S.C. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631957A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631969A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631965A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631968A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631964A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631967A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631963A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631962A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631961A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631958A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide Having Inhibitory Activity Against Osteoclast Differentiation, And Use Thereof

EP4631960A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide Having Activity Of Improving State Of Skin, And Use Thereof

EP4631491A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Use Of Timp3 Recombinant Protein In Preparing Formulation For Inhibiting Hypertension Related Clear Cell Carcinoma Of Kidney

EP2024055443A1 · Shenzhen Institutes of Advanced Technology · Mar 18, 2026
Publication

Dna Tetrahedral Pharmaceutical Complex For Treating Neovascular Retinal Diseases, Preparation Method Therefor, And Use Thereof

EP2024045250A1 · Chengdu Genreze Gene Technology Co., Ltd · Mar 18, 2026
Publication

Antigen Peptide Targeting Flt3 D835 Mutation And Use Thereof In Tumor Immunotherapy

EP2024031811A1 · Ruijin Hospital, Shanghai Jiaotong University School of Medicine · Mar 18, 2026
Publication

Activin Actrii Antagonists And Uses For Treating Myelodysplastic Syndrome

EP4233889A2 · Celgene Corporation · Mar 18, 2026
Publication

O Glycoprotein 2 Acetamido 2 Deoxy 3 D Glycopyranosidase Inhibitors

EP4186899A1 · Biogen MA Inc. · Mar 18, 2026
Publication

8 (Azetidin 1 Yl) [1,2,4]Triazolo[1,5 A] Pyridinyl Compounds, Compositions And Methods Of Use Thereof

EP4198036A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Thyroid Hormone Receptor ¿ Agonist Compounds, Preparation Method Therefor, And Use Thereof

EP2024138317A1 · Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences · Mar 18, 2026
Publication

Methods Of Treating Cardiac Injury

EP4633658A1 · Proletariat Therapeutics, Inc. · Mar 18, 2026
Publication

Methods And Compositions For Altering A Tumor Microbiome

EP4448111A1 · Board of Regents, The University of Texas System · Mar 18, 2026
Publication

Pseudotyped Viral Particles, Compositions Comprising The Same, And Uses Thereof

EP4448550A2 · Interius Biotherapeutics, Inc. · Mar 18, 2026
Publication

Fenfluramine For Treatment Of Demyelinating Diseases And Conditions

EP4395753A1 · Zogenix International Limited · Mar 18, 2026
Publication

Therapeutic Single Domain Antibody

EP4392459A2 · Singh Biotechnology, LLC · Mar 18, 2026
Publication

Compositions And Methods For Anti Virus Chimeric Antigen Receptor

EP4388017A1 · Rudd, Christopher E. · Mar 18, 2026
Publication

Retrograde Coronary Venous Or Sinus Administration Of Therapeutics

EP4384269A1 · Temple University of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Companion Drug Comprising Activity Regulator For T Cell And/Or B Cell

EP4382107A1 · Tokai University Educational System · Mar 18, 2026
Publication

Anti Human Leukocyte Antigen G Nanobody, And Preparation Method Therefor And Use Thereof

EP2024108568A1 · Shenzhen Institutes of Advanced Technology · Mar 18, 2026
Publication

Pharmaceutical Use Of Propofol In Anti Anxiety Drug, And Anti Anxiety Pharmaceutical Preparation

EP2024108501A1 · Mar 18, 2026
Publication

Method For Inhibiting Growth Of Tumor Cells

EP2024108336A1 · Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences · Mar 18, 2026
Publication

Method For Enhancing Broad Spectrum Property Of Vaccine Against Covid 19 Mutant Strains, And Broad Spectrum Covid 19 Vaccine

EP2024103431A1 · Sun Yat-Sen University · Mar 18, 2026
Publication

Bacillus Velezensis Jk1 Strain And Composition For Preventing Or Treating Cancer Comprising Same

EP2024090668A1 · Mbiometherapeutics Co., Ltd. · Mar 18, 2026
Publication

Anti Adhesive Material, And Method For Producing Anti Adhesive Material

EP4506021A1 · National Institute for Materials Science · Mar 18, 2026
Publication

Ophthalmic Suspension Vehicles And Related Methods For Pharmaceutical Ingredient Delivery

EP4561700A1 · Willis, Timothy R. · Mar 18, 2026
Publication

Combination Therapy Comprising A Composition Of Mesenchymal Stromal Cells And Hyaluronic Acid For Use In Treatment Of Osteoarthritis

EP4630016A1 · Stempeutics Research Private Limited · Mar 18, 2026
Publication

Peptide And Composition

EP4368629A1 · OSAKA UNIVERSITY · Mar 18, 2026
Publication

Compositions For Treatment Of Diabetic Symptoms

EP4366728A1 · INNOCAN PHARMA LTD. · Mar 18, 2026
Publication

Tau Tubulin Kinase (Ttbk) Inhibitor Compounds

EP4368182A1 · Consejo Superior De Investigaciones Científicas - CSIC · Mar 18, 2026
Publication

Methods For Making Extracellular Vesicles, And Compositions And Methods Of Use Thereof

EP4419120A2 · Evia Life Sciences Inc. · Mar 18, 2026
Publication

Compostions For Use In The Prophylactic Treatment Of Hypocalcemia In A Ruminant Animal

EP4633381A1 · Vilofoss A/S · Mar 18, 2026
Publication

Bcat2 Inhibitors

EP4430036A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4363425A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Sapovirus Vaccines

EP4362975A2 · VST LLC dba Medgene Labs · Mar 18, 2026
Publication

Regulatory T Cell And Preparation Method Therefor

EP2024108691A1 · SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY · Mar 18, 2026
Publication

Mitomycin C Prodrug, And Preparation Method Therefor And Use Thereof

EP2024108687A1 · SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY · Mar 18, 2026
Publication

Immune Cell Membrane Coated Gold Nanocage Material, And Preparation Method Therefor And Use Thereof

EP2024108658A1 · Shenzhen Institutes of Advanced Technology · Mar 18, 2026
Publication

Composite Material, Method For Preparing Same, And Use Thereof

EP2024108646A1 · Shenzhen Institutes of Advanced Technology · Mar 18, 2026
Publication

Ultrasonically Enhanced Continuous And Large Scale Production Method For Nano Formulations

EP4450045A1 · Shanghai Best-Link Bioscience, LLC · Mar 18, 2026
Publication

Fgfr4 Inhibitor Acid Salt, Preparation Method Therefor, And Use Thereof

EP4450499A1 · Abbisko Therapeutics Co., Ltd. · Mar 18, 2026
Publication

Inhibitors Of Menin Mll Interaction

EP4444300A2 · Bala Therapeutics, Inc. · Mar 18, 2026
Publication

Antibody Binding To Bcma And Use Thereof

EP4446341A1 · Innovent Biologics (Suzhou) Co., Ltd. · Mar 18, 2026
Publication

A Maps Vaccine Targeting Salmonella Enterica Serovars

EP4440606A1 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Method For Improving Loading Efficiency Of Exosomes In Tumor Therapeutic Drug

EP2023098905A1 · Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS) · Mar 18, 2026
Publication

Bifunctional Chimeric Molecules For Labeling Of Kinases With Target Binding Moieties And Methods Of Use Thereof

EP4433458A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Peptides And Uses Thereof

EP4433495A1 · Preveceutical Medical Inc. · Mar 18, 2026
Publication

Bcma Targeting Chimeric Antigen Receptor And Use Thereof

EP4435012A1 · Juventas Co., Ltd. · Mar 18, 2026
Publication

Combination Therapy Of Claudin 18.2 Antagonist And Pd 1/Pd L1 Axis Inhibitor

EP4433510A1 · Suzhou Transcenta Therapeutics Co., Ltd. · Mar 18, 2026
Publication

Antibodies Binding Cldn18.2 And Uses Thereof

EP4419550A1 · Biosion, Inc. · Mar 18, 2026
Publication

Composition Containing Antitumor Drug, And Preparation Method Therefor And Use Thereof

EP4417204A1 · Kunshan Xinyunda Biotech Co., Ltd. · Mar 18, 2026
Publication

Tantalum Nano Complex, And Preparation Method Therefor And Use Thereof, Lymphatic Tracer, And Radiotherapy Sensitizer

EP4417209A1 · Fungo Technology Co., Ltd. · Mar 18, 2026
Publication

Recombinant Newcastle Disease Virus Expressing Spike Protein Of Sars Cov 2 Delta Variant And Uses Thereof

EP4408463A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Peptide Having Anti Aging Activity, And Use Thereof

EP4410817A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Bcl Xl Degraders And Uses Thereof

EP4401729A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Protein And Pharmaceutical Composition Comprising Same For Prevention Or Treatment Of Cancer

EP4403567A1 · Cellemedy Co., Ltd · Mar 18, 2026
Publication

Heteronucleic Acid Including 2' Modified Nucleoside

EP4403191A1 · National University Corporation Tokyo Medical and Dental University · Mar 18, 2026
Publication

Composition Comprising A Polar Phase And A Non Polar Phase

EP4209207A1 · PM-International AG · Mar 18, 2026
Publication

Bisphosphocin Gel Formulations And Uses Thereof

EP4241769A2 · Lakewood Amedex, Inc. · Mar 18, 2026
Publication

Use Of Anti Il 1 Beta Antibodies

EP4218815A2 · Novartis AG · Mar 18, 2026
Publication

Antagonists Of Cav 2.3

EP4436664A1 · Lario Therapeutics Limited · Mar 18, 2026
Publication

Systems And Methods For Regulating Aberrant Gene Expressions

EP4355357A1 · Epicrispr Biotechnologies, Inc. · Mar 18, 2026
Publication

Methods And Compositions For Treating Cancer

EP4355311A1 · Onconova Therapeutics, Inc. · Mar 18, 2026
Publication

Dimeric Collagen Hybridizing Peptides And Methods Of Use Thereof

EP4355769A1 · University of Utah Research Foundation · Mar 18, 2026
Publication

Orally Bioavailable Nucleoside Analogs

EP4355755A1 · Venatorx Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Inhibitory Peptides For The Diagnostic And/Or Treatment Of Tauopathies

EP4441082A1 · Université de Rennes · Mar 18, 2026
Publication

Deuterated (Trifluoromethyl)pyrimidine 2 Amine Compounds As Potentiators Of The Hmrgx1 Receptor

EP4429764A1 · ELI LILLY AND COMPANY · Mar 18, 2026
Publication

Development Of A New Family Of Nanocarriers Derived From Natural Tetrameric Acid Lipids

EP4433449A1 · Université de Rennes · Mar 18, 2026
Publication

Safe Administration Of Mmp 12 Inhibitor

EP4351566A1 · Foresee Pharmaceuticals USA, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Interleukin 7 Receptor Deficiency

EP4426726A1 · The Children's Hospital Of Philadelphia · Mar 18, 2026
Publication

Methods Of Treating Cancer

EP4426360A1 · Fusion Pharmaceuticals Inc. · Mar 18, 2026
Publication

Betacoronavirus Attenuated Strain

EP4431599A1 · The Research Foundation for Microbial Diseases of Osaka University · Mar 18, 2026
Publication

Novel Crystal Forms Of Peptide Boric Acid Compound And Preparation Methods Therefor

EP4431515A1 · Jiangsu Chuangte Pharmaceutical Technology Co., Ltd. · Mar 18, 2026
Publication

Bcma Monoclonal Antibody And The Antibody Drug Conjugate

EP4426741A1 · Hangzhou DAC Biotech Co., Ltd. · Mar 18, 2026
Publication

Compositions For Treatment Of Hair Loss

EP4346801A1 · INNOCAN PHARMA LTD. · Mar 18, 2026
Publication

Lpa Receptor Antagonists And Uses Thereof

EP4444707A1 · GILEAD SCIENCES, INC. · Mar 18, 2026
Publication

Cancer Treatment Combinations

EP4373525A1 · Viracta Subsidiary, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Opioid Dependence And Withdrawal

EP4373484A1 · CASE WESTERN RESERVE UNIVERSITY · Mar 18, 2026
Publication

A Substituted Aromatic Dicarbonic Acid Amide As An Inhibitor Of The Ferroptosis Suppressor Protein 1 (Fsp1)

EP4456888A1 · Julius-Maximilians-Universität Würzburg · Mar 18, 2026
Publication

Methods Of Treating Alzheimer's Disease

EP4370131A1 · Athira Pharma, Inc. · Mar 18, 2026
Publication

Cyclopentathiophene Carboxamide Derivatives As Platelet Activating Factor Receptor Antagonists

EP4452985A1 · BOEHRINGER INGELHEIM INTERNATIONAL GMBH · Mar 18, 2026
Publication

Injectable And Inhalable Formulations Containing Optionally Deuterated Dimethyltryptamine

EP4433049A1 · Cybin UK Ltd · Mar 18, 2026
Publication

Ketamine And Cannabis For The Treatment Of Emotional Disorders

EP4329737A1 · Progressive Therapeutics, Inc. · Mar 18, 2026
Publication

Purification Of Burkholderia Capsular Polysaccharides

EP4330292A1 · Board of Regents of the Nevada System of Higher Education, on Behalf of the University of Nevada, Reno · Mar 18, 2026
Publication

Substituted 2 (2,6 Dioxopiperidin 3 Yl) 5 (1 Piperidin 4 Yl)isoindoline 1,3 Dione Derivatives And Uses Thereof

EP4329744A1 · Neomorph, Inc. · Mar 18, 2026
Publication

Antibodies For The Treatment And Prevention Of Covid 19 And Emerging Variants

EP4330279A2 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Novel Anti Cd5 Chimeric Antigen Receptor And Immune Cell Expressing Same

EP4332118A1 · Korea Research Institute of Bioscience and Biotechnology · Mar 18, 2026
Publication

Coronavirus Vaccines And Methods Of Use

EP4404960A1 · BioNTech SE · Mar 18, 2026
Publication

Coadministration Of Mirodenafil With Cort 108297 For Preventing And Treating Dementia

EP4327813A1 · ARIBIO CO., LTD. · Mar 18, 2026
Publication

Anti Inflammatory Siglec Proteins And Methods Of Making And Using Same

EP4323378A2 · Palleon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Dna Binding Proteins For Regulating Gene Expression

EP4323515A1 · Altius Institute For Biomedical Sciences · Mar 18, 2026
Publication

Synthetic Rocaglates With Broad Spectrum Antiviral Activities And Uses Thereof

EP4322940A1 · Memorial Sloan-Kettering Cancer Center · Mar 18, 2026
Publication

Novel Compositions Enriched In Gamma Delta T Cells, Methods Of Preparation, And Uses Thereof

EP4322972A1 · Acepodia Biotechnologies Ltd. · Mar 18, 2026
Publication

Cell Penetrating Peptide, Anti Cancer Peptide, And Pharmaceutical Composition For Preventing Or Treating Cancer, Comprising Same

EP4324841A1 · Onecuregen Co., Ltd. · Mar 18, 2026
Publication

4 Ethynyl 3 Hydroxy Tetrahydrofuranyl Adenine Phosphoramidates And Related Compounds And Their Use In Treating Medical Conditions

EP4358968A1 · Rome Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Pulmonary Hypertension

EP4358991A1 · Acceleron Pharma, Inc. · Mar 18, 2026
Publication

Pyrazolo[3,4 B]Pyridine Compounds For The Treatment Of Autoimmune Disease

EP4405051A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Methods For Delivering Agents With Pre Filled Syringes To Minimize Intraocular Inflammation

EP4398927A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Antiviral Structurally Stapled Sars Cov 2 Peptide Cholesterol Conjugates And Uses Thereof

EP4399220A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Dosing Of Bispecific T Cell Engager

EP4319815A1 · Anji Bruno, LLC · Mar 18, 2026
Publication

Use Of Sos1 Inhibitors With Ras Inhibitors To Treat Cancers

EP4319745A1 · Revolution Medicines, Inc. · Mar 18, 2026
Publication

Bispecific Molecules And Related Compositions And Methods

EP4314050A1 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

Staphylococcus Aureus Vaccine Compositions

EP4313303A1 · Janssen Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Pyrimidine Derivative Having Protein Kinase Inhibitory Activity, And Therapeutic Pharmaceutical Composition Comprising Same

EP4286376A1 · Therapex Co., Ltd. · Mar 18, 2026
Publication

Heteroaryl Derivatives As Pd1/Pd L1 Inhibitors For The Treatment Of Hbv And Cancer

EP4313968A2 · Arbutus Biopharma Corporation · Mar 18, 2026
Publication

Biomarkers For Sting Agonists And Methods Of Using The Same

EP4398901A1 · Eisai R&D Management Co., Ltd. · Mar 18, 2026
Publication

Compounds For Regulating Trained Immunity, And Their Methods Of Use

EP4308105A1 · Trained Therapeutix Discovery, Inc. · Mar 18, 2026
Publication

Compounds For The Treatment Of Disorders And Salts And Polymorphs Thereof

EP4308541A1 · OccuRx Pty Ltd · Mar 18, 2026
Publication

Reconstitution And Uses Of Flavivirus Epitopes

EP4347622A1 · Ramot at Tel-Aviv University Ltd. · Mar 18, 2026
Publication

Phosphate Of Trifluoromethyl Substituted Sulfonamide Compound

EP4353722A1 · CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. · Mar 18, 2026
Publication

Skin Care Composition

EP4433019A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Nitroxoline For Use In The Treatment Or Prevention Of A Plexiform Neurofibroma

EP4433054A1 · Healx Limited · Mar 18, 2026
Publication

Cell Therapies For The Treatment Of Small Volume Stroke

EP4346853A1 · SanBio, Inc. · Mar 18, 2026
Publication

Extraction And Purification Of The Distillation Residues Of Black Spruce And Labrador's Tea And Combination Thereof

EP4351608A1 · Silicycle Inc. · Mar 18, 2026
Publication

Pharmaceutical Composition And Kit Comprising An Immunomodulatory Substance For Treating Diseases

EP4422671A1 · ellennbe GmbH · Mar 18, 2026
Publication

Medical Device Comprising A Skin Conditioning Unit And An Applicator Unit

EP4422669A1 · ellennbe GmbH · Mar 18, 2026
Publication

Tyk2 Degraders And Uses Thereof

EP4423086A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Engineered Antimicrobial Peptides And Usage Thereof

EP4337321A2 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Immunomodulation Of Tumor Microenvironment

EP4340682A1 · Genkin, Dmitry Dmitrievich · Mar 18, 2026
Publication

Polyclonal Antibodies To Treat Respiratory Syncytial Virus

EP4351646A1 · Lactiga, Inc. · Mar 18, 2026
Publication

Indications For Anti Prame Binders

EP4412642A2 · immatics biotechnologies GmbH · Mar 18, 2026
Publication

Composition For Reducing The Concentration Of Viruses And Of African Swine Fever Virus (Asfv) In Animal Feed And Litter Materials For Stables

EP4412470A1 · Dr. Eckel Vermögensverwaltung GmbH · Mar 18, 2026
Publication

Peptide Fc Fusions For Treating Amyloid Disorders

EP4333871A1 · University of Tennessee Research Foundation · Mar 18, 2026
Publication

Cdk2 Degraders And Uses Thereof

EP4334307A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Topical Compositions Of 2 Phenyl 3,4 Dihydropyrrolo[2,L F] [1,2,4]Triazinone Derivatives And Uses Thereof

EP4408391A1 · Topadur Pharma AG · Mar 18, 2026
Publication

Mesenchymal Stem Cells For Use In Treating Diabetes Caused By Immune Checkpoint Inhibitors

EP4134088A1 · Rohto Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Ibudilast For Preventing Eye Cancer Metastasis

EP4376838A1 · MediciNova, Inc. · Mar 18, 2026
Publication

Irak4 Degraders And Uses Thereof

EP4291197A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak4 Degraders And Uses Thereof

EP4291187A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Biomarkers For Cancer Treatment

EP4291902A2 · Foundation Medicine, Inc. · Mar 18, 2026
Publication

Recombinant Human Acid Alpha Glucosidase And Uses Thereof

EP4291225A1 · Amicus Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Improving Relaxation, Sleep, Cognition, And/Or Physical Performance

EP4288039A1 · Health Via Modern Nutrition Inc. · Mar 18, 2026
Publication

Methods For Treating Autism Spectrum Disorder

EP4288150A1 · The General Hospital Corporation · Mar 18, 2026
Publication

Preventive Or Therapeutic Agent For Inflammatory Disorders And/Or Pain Disorders

EP4272759A1 · Kyowa Pharma Chemical Co., Ltd. · Mar 18, 2026
Publication

Novel Boron Carrier, Preparation Method And Pharmaceutical Formulation Thereof

EP4324836A1 · Peking University · Mar 18, 2026
Publication

Drug Conjugate Of Glucocorticoid Receptor Agonist, And Application Thereof In Medicine

EP4289857A1 · Shanghai Senhui Medicine Co., Ltd. · Mar 18, 2026
Publication

Crystal Form Of 3 Hydroxy 5 Pregnane 20 One Derivative, And Preparation Method Therefor And Use Thereof

EP4289856A1 · TWi Biotechnology, Inc. · Mar 18, 2026
Publication

Chimeric Antigen Receptor With Endogenous Protein Molecule Replacing Single Domain Antibody

EP4289867A1 · Zhejiang University · Mar 18, 2026
Publication

Nucleotide Mixture For Use In Treating Allergic Rhinitis

EP4108245A1 · Chen, Yusong · Mar 18, 2026
Publication

Methods And Compositions For Tau Reduction Gene Therapy

EP4362986A1 · THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM · Mar 18, 2026
Publication

Epigenetic Gene Regulation To Treat Neurological Diseases And Pain

EP4284927A2 · Navega Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions Comprising Hiv Envelopes To Induce Hiv 1 Antibodies

EP4284427A1 · Duke University · Mar 18, 2026
Publication

Immunosuppressive Pharmaceutical Composition Including Benzene Derivative As Immunosuppressant

EP4271369A1 · Provibio Co., Ltd. · Mar 18, 2026
Publication

Pharmaceutical Composition For Treating Liver Diseases Using Ssu72

EP4247415A1 · Curogen Technology Co., Ltd. · Mar 18, 2026
Publication

Phenol Derivative And Application Thereof In Medicaments

EP4286359A1 · Hinye Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Antibody Drug Conjugate, Preparation Method Therefor And Application Thereof

EP4331616A1 · Tsinghua University · Mar 18, 2026
Publication

Alkyl Carboxylic Acid Compounds And Application Thereof

EP4339184A1 · Medshine Discovery Inc. · Mar 18, 2026
Publication

1 Methylxanthine Based Bioactive Composition And Method Of Use Thereof

EP4319759A1 · Ingenious Ingredients, LP · Mar 18, 2026
Publication

Cationic Lipid, Liposome Containing Cationic Lipid, And Nucleic Acid Pharmaceutical Composition Containing Liposome And Preparation And Application Thereof

EP4276090A1 · Xiamen Sinopeg Biotech Co., Ltd. · Mar 18, 2026
Publication

Artemisinin Proteasome Inhibitor Conjugates And Their Use In The Treatment Of Disease

EP4281066A2 · Cornell University · Mar 18, 2026
Publication

Hydroxybisphosphonic Derivatives Of Meloxicam For The Treatment Of Inflammatory Joint Diseases

EP4330264A1 · Atlanthera · Mar 18, 2026
Publication

Pyridine Sulfonamide Derivatives As Sigma Ligands

EP4330248A1 · Acondicionamiento Tarrasense · Mar 18, 2026
Publication

Dosing Regimens

EP4337205A1 · Novartis AG · Mar 18, 2026
Publication

Small Molecule Antagonists For The Relaxin 3/Rxfp3 System

EP4304630A1 · Research Triangle Institute · Mar 18, 2026
Publication

Branched Linkers For Antibody Drug Conjugates And Methods Of Use Thereof

EP4301415A1 · R.P. Scherer Technologies, LLC · Mar 18, 2026
Publication

Arylsulfoxamides As Orexin Receptor Agonists

EP4301728A1 · Research Triangle Institute · Mar 18, 2026
Publication

Vaccines For The Treatment And Prevention Of Zoonotic Infections

EP4301406A1 · Longhorn Vaccines and Diagnostics, LLC · Mar 18, 2026
Publication

Compositions And Methods For Enhancing Anti Viral Therapies

EP4301355A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Iron Complex Compounds For Subcutaneous Use In Therapy Of Iron Deficiency In Companion Animals

EP4380581A1 · Pharmacosmos Holding A/S · Mar 18, 2026
Publication

Compositions And Methods For Treating Canine Parvovirus Infection

EP4297745A1 · MOXXITECH, LLC · Mar 18, 2026
Publication

Heteroaryl Derivatives As Apelin Receptor Agonists

EP4298091A1 · Research Triangle Institute · Mar 18, 2026
Publication

Composition, For Preventing, Relieving, Or Treating Disease Caused By Nitration Of Protein, Containing Peptide Having Tyrosine Located At Terminal As Active Ingredient

EP4298924A1 · Industry-Academic Cooperation Foundation Gyeongsang National University · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4294790A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Systems, Devices, And Formulations For Time Phased Histamine Delivery

EP4294446A1 · Agonex Biopharmaceuticals, Inc. · Mar 18, 2026
Publication

Stable Isoquinoline Corticosteroid Conjugates And Uses Thereof

EP4330267A1 · Aerie Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Substituted Hydantoin Compounds, Methods For Preparation Thereof And Use Thereof In The Treatment And/Or Prevention Of A Corona Virus Disease

EP4329883A1 · Carlsson, Jens · Mar 18, 2026
Publication

Acetyl Sh Hexapeptide 5 Amide Acetate For Use In The Treatment Of Hair Loss Disorders And As A Hair Care Agent

EP4326305A1 · Laboratorio Genove, S.A. · Mar 18, 2026
Publication

Urea Derivatives For Treating Uveal Melanoma

EP4322944A1 · Centre National de la Recherche Scientifique · Mar 18, 2026
Publication

Spirocyclic Imidazolidinones And Imidazolidinediones For Treatment Of Light Chain Amyloidosis

EP4326721A1 · Protego Biopharma, Inc. · Mar 18, 2026
Publication

Modulation Of Antibody Dependent Cellular Cytotoxicity

EP4326333A1 · Seagen Inc. · Mar 18, 2026
Publication

New Pyrazolo[1,5 A]Pyrimidine Derivatives As Sigma Ligands

EP4323363A1 · Acondicionamiento Tarrasense · Mar 18, 2026
Publication

Combination Product And Methods For Preventing The Emergence Of Antibiotic Resistant Bacteria Under Antibiotic Treatment

EP4329760A1 · Diotheris · Mar 18, 2026
Publication

Wnt5 A Peptides For The Treatment Of Acute Myelogenous Leukemia

EP4346873A1 · Wntresearch AB · Mar 18, 2026
Publication

Individualized Cell Therapy Using Patient Derived Antigen Specific Regulatory T Cells

EP4373517A1 · Phaim Pharma Ltd · Mar 18, 2026
Publication

Unsaturated Hydroxamic Acid Derivatives And Their Use For The Treatment And Prevention Of An Ammonia Associated Disease Or Disorder

EP4362928A1 · Genfit · Mar 18, 2026
Publication

Substituted Salicylamide Compounds And Use Thereof

EP4277884A1 · Helios Huaming Biopharma Co., Ltd. · Mar 18, 2026
Publication

Probiotic Containing An L. Casei Strain And Its Uses In Malnutritional Situations

EP4351606A1 · Institut National de la Recherche pour l'Agriculture, l'Alimentation et l'Environnement · Mar 18, 2026
Publication

Vedolizumab Formulation

EP4346899A1 · Polpharma Biologics S.A. · Mar 18, 2026
Publication

In Vivo Lentiviral Gene Therapy For The Treatment Of Primary Hyperoxaluria Type 1

EP4330415A1 · Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. · Mar 18, 2026
Publication

Enantiomers Of Substituted Thiazoles As Antiviral Compounds

EP4209491A1 · Innovative Molecules GmbH · Mar 18, 2026
Publication

Protein Comprising Nc 1 For Treating Angiogenesis Related Diseases

EP4215206A1 · Heidelberg Biotech GmbH · Mar 18, 2026
Publication

Composition Comprising Bifidobacterium Longum Strains Ncimb 41003 And Ncimb 41676 For Use In Treating Irritable Bowel Syndrome

EP4154722A1 · PrecisionBiotics Group Limited · Mar 18, 2026
Publication

Non Viral Dna Vectors Expressing Anti Coronavirus Antibodies And Uses Thereof

EP4329884A1 · Generation Bio Co. · Mar 18, 2026
Publication

New Pharmaceutical Composition For Drug Delivery

EP4154866A1 · Orexo AB · Mar 18, 2026
Publication

Therapy For Inhibition Of Single Stranded Rna Virus Replication

EP4134076A1 · Redhill Biopharma Ltd. · Mar 18, 2026
Publication

Antibody Therapeutics That Bind Cd38

EP4180058A1 · Vivasor, Inc. · Mar 18, 2026
Publication

Acebutolol Hydrochloride For Use In Treating Psoriasis

EP4342462A1 · Sun, Liangdan · Mar 18, 2026
Publication

Heterocyclic Compounds As Ret Kinase Inhibitors

EP4104837A2 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Pyrazolopyrimidine Compounds Useful As Ret Inhibitors

EP4105219A1 · Cancer Research Technology Limited · Mar 18, 2026
Publication

2,4 Diaminoquinazoline Derivatives And Medical Uses Thereof

EP4059924A1 · Janssen Sciences Ireland Unlimited Company · Mar 18, 2026
Publication

Treatment Of Overactive Bladder With Oxybutynin Applied By Means Of A Vaginal Ring

EP4297744A1 · Ligalli B.V. · Mar 18, 2026
Publication

Amiselimod For Preventing, Treating, Or Ameliorating Ulcerative Colitis

EP4288041A1 · Bausch Health Ireland Limited · Mar 18, 2026
Publication

Coupling Endonucleases With End Processing Enzymes Drives High Efficiency Gene Disruption

EP4062927A1 · Seattle Children's Research Institute · Mar 18, 2026
Publication

Antibodies Specifically Binding Pd 1 And Their Uses

EP4046655A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

Compositions For Rejuvenating Skeletal Muscle Stem Cells

EP4140497A1 · President and Fellows of Harvard College · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4271664A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Modified Reovirus And Use Thereof

EP4268837A1 · Virocure, Inc. · Mar 18, 2026
Publication

Tnf Alpha And Ngf Antibodies For Veterinary Use

EP4263603A2 · Elanco US Inc. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4259144A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Tetrahydroquinazoline Derivatives As Selective Cytotoxic Agents

EP4259608A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Boronic Acid Compounds

EP4242213A1 · LG Chem, Ltd. · Mar 18, 2026
Publication

Peptide Receptor Radionuclide Therapy

EP4255891A1 · The Regents of University of California · Mar 18, 2026
Publication

Heterocyclic Derivatives As Janus Kinase Inhibitors

EP4308122A1 · Chiesi Farmaceutici S.p.A. · Mar 18, 2026
Publication

Oligonucleotide Ligand Conjugates And Process For Their Preparation

EP4039278A1 · Alnylam Pharmaceuticals, Inc. · Mar 18, 2026
Publication

1,4 Disubstituted Pyridazine Derivatives And Their Use For Treating Smn Deficiency Related Conditions

EP4105208A1 · Novartis AG · Mar 18, 2026
Publication

Long Acting Compstatin Analogs And Uses Thereof

EP4105224A1 · Apellis Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Antibodies Binding Cd24, Preparation And Use Thereof

EP4166196A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Antibodies Binding Cd70, Preparation And Use Thereof

EP4166571A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Anti Vegf Anti Pd L1 Bispecific Antibody, Pharmaceutical Composition Of Same, And Uses Thereof

EP4209513A1 · Biotheus Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Mesothelin Positive Cancers

EP4100028A1 · A2 Biotherapeutics, Inc. · Mar 18, 2026
Publication

Compounds For Prevention Or Treatment Of Neurodegenerative Disorders

EP4200299A1 · 1st Biotherapeutics, Inc. · Mar 18, 2026
Publication

Pyrimidinone Compounds And Uses Thereof

EP4200281A1 · Hutchison Medipharma Limited · Mar 18, 2026
Publication

Anti Cd73 Antibody And Use Thereof

EP4197555A1 · Akeso Biopharma, Inc. · Mar 18, 2026
Publication

Humanized Antibody, Chimeric Antigen Receptor, Nucleic Acid, Vector, Cell And Use

EP4190808A1 · Shenzhen Immunofoco Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Proteasome Enhancers And Uses Thereof

EP4196121A1 · Board Of Trustees Of Michigan State University · Mar 18, 2026
Publication

Donepezil Ether Palmitate Or Pharmaceutically Acceptable Salt Thereof

EP4198021A1 · Chong Kun Dang Pharmaceutical Corp. · Mar 18, 2026
Publication

Compositions Comprising Ketotifen And A Non Steroidal Anti Inflammatory Drug Selected From Naproxen Or Indomethacin For Use In The Treatment Of A Beta Coronavirus Infection

EP4192457A1 · Sen-Jam Pharmaceutical LLC · Mar 18, 2026
Publication

Inhibitors Of Short Chain Dehydrogenase Activity For Treating Neurodegeneration

EP4192455A1 · CASE WESTERN RESERVE UNIVERSITY · Mar 18, 2026
Publication

Therapeutic Targeting Of Phosphate Dysregulation In Cancer Via The Xpr1:Kidins220 Protein Complex

EP4192486A1 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Polypeptides Rv3 And Rv4 Having Anti Aging Function And Applications Thereof

EP4190798A1 · Nanjing Anji Biological Technology Co., Ltd · Mar 18, 2026
Publication

Formulation Of Novel Bispecific Anti Cd3/Cd20 Polypeptide Complex

EP4190352A1 · CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. · Mar 18, 2026
Publication

Salt And Crystal Form Of Pyrimidine Compound, And Preparation Methods Therefor

EP4190781A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Compositions And Methods For Treating Bacterial Infections

EP4188424A1 · Mucpharm Pty Ltd · Mar 18, 2026
Publication

Antivirus Proteins Having A Kringle 5 Subunit

EP4319878A1 · CREATIVE BIOTHERAPEUTICS, LLC · Mar 18, 2026
Publication

Novel Bacteriophage Having Enterotoxigenic Escherichia Coli Specific Bactericidal Effect And Antibacterial Composition Comprising Same

EP4299725A1 · CJ Cheiljedang Corporation · Mar 18, 2026
Publication

Target Cell Restricted, Costimulatory, Bispecific And Bivalent Anti Cd28 Antibodies

EP4240762A1 · Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts · Mar 18, 2026
Publication

Linear Apelin Receptor Agonists

EP4225773A1 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Triple Combination Therapy For Enhancing Cancer Cell Killing In Cancers With Low Immunogenicity

EP4146216A1 · Beyondspring Pharmaceuticals Inc. · Mar 18, 2026
Publication

Methods For Treating Endometrial Cancer

EP4143569A1 · Mayo Foundation for Medical Education and Research · Mar 18, 2026
Publication

Precision Dosing Regimen

EP4142755A1 · Children's Hospital Medical Center · Mar 18, 2026
Publication

Novel Therapy For Acute Damage To Lung Tissue

EP4138916A1 · Remodeless CV Ltd. · Mar 18, 2026
Publication

Single Variable Domain Antibody Targeting Human Programmed Death Ligand 1 (Pd L1) And Derivative Thereof

EP4144758A1 · Mabwell (Shanghai) Bioscience Co., Ltd. · Mar 18, 2026
Publication

Thiohydroxypyridine Chelates

EP4232029A1 · Lumiphore, Inc. · Mar 18, 2026
Publication

Proinflammatory Prodrugs

EP4232093A1 · THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM · Mar 18, 2026
Publication

Cytokine Storm Inhibitor, Method For Using Cytokine Storm Inhibitor, And Method For Screening For Cytokine Inhibitor

EP4212163A1 · Dexon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Chebulinic Acid And Its Enriched Fraction From The Fruits Of Terminalia Chebula For Treatment Of Benign Prostatic Hyperplasia (Bph) And Its Preparation Thereof

EP4210721A1 · Council of Scientific and Industrial Research · Mar 18, 2026
Publication

Novel Biaryl Derivative Useful As Diacylglycerol Acyltransferase 2 Inhibitor, And Use Thereof

EP4206193A1 · LG Chem, Ltd. · Mar 18, 2026
Publication

Pharmaceutical Composition For Treatment Of Hypertrophic Cardiomyopathy And Treatment Method Using Same Composition

EP4140482A1 · Celltrion, Inc. · Mar 18, 2026
Publication

Cry?B2 Predicts Poor Breast Cancer Outcome And Sensitizes Tumors To Nucleolin And Cdk Inhibition

EP4135850A1 · The Johns Hopkins University · Mar 18, 2026
Publication

Decoy Transcripts For Treatment Of Ssrna Viral Infection

EP4136232A1 · Tel HaShomer Medical Research Infrastructure and Services Ltd. · Mar 18, 2026
Publication

Combination Of A Sting Agonist And A Complex Comprising A Cell Penetrating Peptide, A Cargo And A Tlr Peptide Agonist

EP4228681A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Compositions Comprising Nanoparticles, Method Of Making And Uses Thereof

EP4132548A1 · Organicell Regenerative Medicine, Inc. · Mar 18, 2026
Publication

Methods And Compositions For Preventing And Treating Retinal Nerve Damage

EP4132537A1 · G3P, Inc. · Mar 18, 2026
Publication

Octahydropyrazinodiazanaphthyridine Dione Compounds

EP4129997A1 · Medshine Discovery Inc. · Mar 18, 2026
Publication

Methods And Treatment Involving Excess Free Light

EP4126945A2 · Avalo Therapeutics, Inc. · Mar 18, 2026
Publication

Administration Of Sting Agonist, Checkpoint Inhibitors, And Radiation

EP4247385A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Amorphous Solid Dispersions

EP4262756A1 · UCB Biopharma SRL · Mar 18, 2026
Publication

Multi Parallel Analysis Of T Cell Therapies

EP4178590A1 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

New Aryl Pyrido Pyrimidin One Derivatives

EP4263541A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

A Method For Killing, Reducing The Viability Of, And/Or Preventing The Germination Of Spores Of A Bacterium

EP4262391A1 · Hankkija Oy · Mar 18, 2026
Publication

Pharmaceutical Compositions Of 6 (2 (2 H Tetrazol 5 Yl)ethyl) 6 Fluorodecahydroisoquinoline 3 Carboxylic Acid And Ester Derivatives Thereof

EP4175635A1 · Sea Pharmaceuticals LLC · Mar 18, 2026
Publication

Compositions And Methods For Modulating Hair Growth

EP4172159A1 · The Regents of the University of California · Mar 18, 2026
Publication

Use Of Palovarotene In Treatment Against Hbv Virus

EP4186505A1 · Yang Sheng Tang Company, Ltd. · Mar 18, 2026
Publication

Crystalline Forms Of Irak Degraders

EP4161575A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Deuterated Irak Degraders And Uses Thereof

EP4161521A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Antibody Drug Conjugates

EP4240488A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Piperidine 2,6 Diones As Small Molecule Degraders Of Helios And Methods Of Use

EP4153175A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

A Process For Preparing A Pharmaceutical Preparation

EP4251184A1 · Dr Dozo Laboratories · Mar 18, 2026
Publication

Compositions For And Methods Of Enhancing Tissue Regeneration

EP4222163A1 · Duke University · Mar 18, 2026
Publication

Recombinant Adeno Associated Viruses With Enhanced Liver Tropism And Uses Thereof

EP4244360A1 · Beijing SoloBio Genetechnology Company Ltd. · Mar 18, 2026
Publication

Polypeptides For Use In The Treatment And Prevention Of Neurodegenerative Diseases

EP4232066A1 · Immune System Key Ltd. · Mar 18, 2026
Publication

Pharmaceutical Compositions And Methods Of Using The Same For Treating Cancer

EP4237094A1 · Otsuka Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Cinnamein Composition For Use In The Treatment Of Urea Cycle Disorders

EP4236966A1 · Rush University Medical Center · Mar 18, 2026
Publication

Method And Drug For Promoting Degradation Of Misfolded Protein And Aggregate Thereof

EP4122489A1 · Talengen International Limited · Mar 18, 2026
Publication

Treatment Of Inflammatory Diseases With Peptides And Pharmaceutical Compositions

EP4114430A2 · YUYU Pharma, Inc. · Mar 18, 2026
Publication

Mdm2 Degraders And Uses Thereof

EP4121043A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Combination Of Merestinib With Ly2584702 For The Treatment Of Glioblastoma

EP4117787A1 · University of Cincinnati · Mar 18, 2026
Publication

Compositions Derived From Salvia Hispanica Seeds

EP4114425A1 · Signum Biosciences, Inc. · Mar 18, 2026
Publication

Ferroptosis Inhibitors Diarylamine Para Acetamides

EP4114375A1 · Sironax Ltd. · Mar 18, 2026
Publication

Ketorolac For Use In The Treatment Of Cytokine Storm And Cytokine Release Syndrome

EP4110329A1 · Yinuoke Medicine Science Technology Company Ltd. · Mar 18, 2026
Publication

Anti Tumor Composition

EP4112065A1 · SPH Sine Pharmaceutical Laboratories Co., Ltd · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4100004A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Tetrahydropyrazolo Pyrazinyl Dihydroimidazolone Or Tetrahydropyrazolo Pyridinyl Dihydroimidazolone Compounds And Methods Of Using Same

EP4182020A1 · Eccogene Inc. · Mar 18, 2026
Publication

Pharmaceutical Use Of Ketoamide Based Compound

EP4098258A1 · Shanghai Institute of Materia Medica, Chinese Academy of Sciences · Mar 18, 2026
Publication

Compounds And Uses Thereof

EP4096668A1 · Foghorn Therapeutics Inc. · Mar 18, 2026
Publication

Indazole Derivatives As Cannabanoid Receptor Partial Agonists

EP4097088A1 · Research Triangle Institute · Mar 18, 2026
Publication

Pharmaceutical Composition For Preventing Or Treating Alzheimer's And Use Thereof

EP4091635A1 · Toolgen Incorporated · Mar 18, 2026
Publication

Combination Cancer Therapy Using Chk Inhibitor

EP4087563A1 · Shanghai Huayu Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Cycloalkyl Pyrimidines As Ferroportin Inhibitors

EP4143178A1 · Global Blood Therapeutics, Inc. · Mar 18, 2026
Publication

(S) 2 Amino 6 ((3 Aminopropyl)amino)hexanoic Acid (Apl) For Use In The Treatment Of Non Alcoholic Steatohepatitis (Nash), Liver Inflammation, Hepatocellular Ballooning, Liver Fibrosis And Steatosis

EP4138812A1 · Temple University - Of The Commonwealth System of Higher Education · Mar 18, 2026
Publication

Method Of Selecting Patients For Treatment With A Combination Of An Axl Inhibitor And An Immune Checkpoint Modulator

EP4138823A1 · BerGenBio ASA · Mar 18, 2026
Publication

Azalactam Compounds As Hpk1 Inhibitors

EP4143186A1 · Pfizer Inc. · Mar 18, 2026
Publication

Composition For Improving Cognitive Function

EP4135676A1 · Activ'Inside · Mar 18, 2026
Publication

Pd 1 Specific Antisense Oligonucleotide And Its Use In Therapy

EP4143318A1 · Secarna Pharmaceuticals GmbH & Co. KG · Mar 18, 2026
Publication

New Triazinoindole Compounds

EP4143192A1 · JANSSEN Pharmaceutica NV · Mar 18, 2026
Publication

Bicyclic Kinase Inhibitors And Uses Thereof

EP4143191A2 · iOmx Therapeutics AG · Mar 18, 2026
Publication

Furin Inhibitors For Treating Coronavirus Infections

EP4125897A1 · BP Asset V, Inc. · Mar 18, 2026
Publication

Novel Combination For The Treatment Of Aids

EP4138910A1 · 21C BIO · Mar 18, 2026
Publication

Antibody Molecule Drug Conjugates And Uses Thereof

EP4126064A1 · Visterra, Inc. · Mar 18, 2026
Publication

A Composition Comprising Lactobacillus Strains For Treating Or Preventing Conditions Of Elevated Serum Urate

EP4185309A1 · Beo Therapeutics · Mar 18, 2026
Publication

Preterm Labour With Prostaglandin E2 Receptor Agonists

EP4188354A1 · Imperial College Innovations Limited · Mar 18, 2026
Publication

Topical Roflumilast Formulation Having Improved Delivery And Plasma Half Life

EP4096630A1 · Arcutis Biotherapeutics, Inc. · Mar 18, 2026
Publication

Bispecific Factor Viii Mimetic Antibodies

EP4097141A1 · Novo Nordisk A/S · Mar 18, 2026
Publication

Alk5 Inhibitor Conjugates And Uses Thereof

EP4087657A1 · Synthis Therapeutics, Inc. · Mar 18, 2026
Publication

Substituted Triazinones As Thyroid Hormone Receptor Agonists

EP4090652A1 · Eccogene Inc. · Mar 18, 2026
Publication

Treatment Of Membranous Nephropathy, Igg4 Related Disease, And Antiphospholipid Syndrome Using Btk Inhibitor 2 [(3 R) 3 [4 Amino 3 (2 Fluoro 4 Phenoxy Phenyl)pyrazolo[3,4 D]Pyrimidin 1 Yl]Piperidine 1 Carbonyl] 4 Methyl 4 [4 (Oxetan 3 Yl)piperazin 1 Yl]Pent 2 Enenitrile

EP4087577A1 · Principia Biopharma Inc. · Mar 18, 2026
Publication

Single Cell Pathology Analysis Of Tumour Samples

EP4090970A1 · Universität Zürich · Mar 18, 2026
Publication

Testosterone Containing Pharmaceutical Composition

EP4065126A1 · Neurocrine UK Limited · Mar 18, 2026
Publication

Pharmaceutical Compositions Comprising Bictegravir

EP4153181A1 · GILEAD SCIENCES, INC. · Mar 18, 2026
Publication

P38 Alpha Mitogen Activated Protein Kinase Inhibitors

EP4153303A1 · GEN1E Lifesciences Inc. · Mar 18, 2026
Publication

Use Of Trehalose As Prebiotic For Inhibiting Ailment Inducing Microorganisms

EP4178528A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Anti Cd40 Antibody Combination Treatment For Cancer

EP4143230A1 · Seagen Inc. · Mar 18, 2026
Publication

Antibody Drug Conjugates (Adcs) Comprising An Anti Trop 2 Antibody, Compositions Comprising Such Adcs, As Well As Methods Of Making And Using The Same

EP4146283A1 · Levena (Suzhou) Biopharma Co., Ltd. · Mar 18, 2026
Publication

Lymphocytes Expressing Heterologous Targeting Constructs

EP4015525A2 · GammaDelta Therapeutics Limited · Mar 18, 2026
Publication

Compositions For Use In Modulating The Gut Microbiota And Managing Weight

EP3915552A1 · Lpoxy Therapeutics, Inc. · Mar 18, 2026
Publication

Immunoassay Of S Adenosylmethionine Using Analogs Thereof And Personalized Therapeutics

EP3915584A2 · Hao, Xiujuan · Mar 18, 2026
Publication

Use Of Small Molecules To Enhance Mafa Expression In Pancreatic Endocrine Cells

EP3954759A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

Orodispersible Effervescent Tablet Comprising Budesonide For Use In The Treatment Of Eosinophilic Esophagitis

EP4091615A1 · Dr. Falk Pharma GmbH · Mar 18, 2026
Publication

Phospholipids And Phospholipid Metabolites For Treating Viral And Bacterial Pneumonia And Sepsis

EP4135714A1 · Massing, Ulrich · Mar 18, 2026
Publication

Particles, Dna & Rna

EP4136218A1 · Novoscope IP Limited · Mar 18, 2026
Publication

Treating Pulmonary Inflammatory Disease Associated With Covid 19 By Administering Resiniferatoxin

EP4125871A1 · Vivasor, Inc. · Mar 18, 2026
Publication

Pharmaceutical Composition For Treating Inflammatory Bowel Diseases

EP4132473A1 · Cvasthera · Mar 18, 2026
Publication

Vaccine Compositions For Preventing Coronavirus Disease

EP4106809A1 · International AIDS Vaccine Initiative, Inc. · Mar 18, 2026
Publication

Pharmaceutical Compositions Of A Therapeutic Polyene Macrolide And Methods Of Their Use

EP4110305A1 · Biosergen AS · Mar 18, 2026
Publication

Peptides As Selective Gip Receptor Agonists

EP4110800A1 · SANOFI · Mar 18, 2026
Publication

Macrocyclic Pad4 Inhibitors Useful As Immunosuppressant

EP4100405A1 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Trop2 Targeting Antibody Drug Conjugate, And Preparation Method And Use Therefor

EP4265275A1 · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Peptides And Uses Thereof

EP4132957A1 · Sintica Biotech Societa a Responsabilita Limitata Semplificata · Mar 18, 2026
Publication

Combination Treatment For Cancer Based Upon An Icos Antibody And A Pd L1 Antibody Tgf Beta Receptor Fusion Protein

EP4136105A1 · GlaxoSmithKline Intellectual Property Development Limited · Mar 18, 2026
Publication

Combination Treatment For Cancer Involving Anti Icos And Anti Pd1 Antibodies, Optionally Further Involving Anti Tim3 Antibodies

EP4136113A1 · GlaxoSmithKline Intellectual Property Development Limited · Mar 18, 2026
Publication

Anti Cd30 Chimeric Antigen Receptor And Its Use

EP3995512A1 · Abken, Hinrich · Mar 18, 2026
Publication

Flavagline Derivatives

EP3998257A1 · PIERRE FABRE MEDICAMENT · Mar 18, 2026
Publication

Combination Therapy For Use In The Treatment Of Patients Having Acute And/Or Persistent Dyspnea

EP4023218A1 · S-Form Pharma · Mar 18, 2026
Publication

Formulations Of Polyalkylene Oxide Asparaginase And Methods Of Making And Using The Same

EP4019007A1 · Servier IP UK Limited · Mar 18, 2026
Publication

Compounds And Compositions As Inhibitors Of Endosomal Toll Like Receptors

EP4059934A1 · Novartis AG · Mar 18, 2026
Publication

Recombinant Fusion Proteins Targeting Cd47 And Pd L1, Preparation And Use Thereof

EP4151229A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Improved Cell Compositions And Methods For Cancer Therapy

EP4101461A1 · Hadasit Medical Research Services and Development Ltd. · Mar 18, 2026
Publication

Polyvalent Derivatives Of Emoxypine

EP3920921A1 · Riesner Verwaltungs GmbH · Mar 18, 2026
Publication

Small Molecule Analogs Of The Protein E4 Orf1 In The Treatment And Prevention Of Metabolic Disorders

EP3908308A1 · Texas Tech University System · Mar 18, 2026
Publication

Small Molecule Degraders Of Fkbp12 Via Recruitment Of Von Hippel Lindau E3 Ubiquitin Ligase (Vhl) E3 Ubiquitin Ligase, And Uses In Dtag Systems

EP3908291A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Gluten Intolerance And Disorders Arising Therefrom

EP3943104A1 · Codexis, Inc. · Mar 18, 2026
Publication

Plant Srna Extract For Use As An Immunosuppressive Agent

EP3907288A1 · Fondazione Edmund Mach · Mar 18, 2026
Publication

Aav Vectors For Retinal And Cns Gene Therapy

EP3913061A1 · Genzyme Corporation · Mar 18, 2026
Publication

Sterile Therapeutic Composition Formulated For Enteral Administration Comprising One Or More Amino Acids For Use In Treating Dehydration Associated With Injury To The Small Intestine

EP3970715A1 · University of Florida Research Foundation, Inc. · Mar 18, 2026
Publication

Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties

EP3888690A2 · MedImmune, LLC · Mar 18, 2026
Publication

Immunogenic Composition And Vaccine Containing Chlamydia Ssp. Surface Antigens And Its Use

EP4032545A1 · Medizinische Hochschule Hannover · Mar 18, 2026
Publication

Car T Cells Targeting Bcma And Uses Thereof

EP3962949A1 · Celyad S.A. · Mar 18, 2026
Publication

3 Amino 4 H Benzo[E][1,2,4]Thiadiazine 1,1 Dioxide Derivatives As Inhibitors Of Mrgx2

EP3962901A1 · Solent Therapeutics, LLC · Mar 18, 2026
Publication

Self Assembled Nano Fibers As Hemostatic Agent

EP3937952A1 · National Institute of Technology Rourkela · Mar 18, 2026
Publication

Composition Comprising Citrate And Carnitine Able To Activate The Production Of The Protein Klotho

EP3976006A1 · Iperboreal Pharma Srl · Mar 18, 2026
Publication

Inhibitors Of Human Immunodeficiency Virus Replication

EP3962603A1 · ViiV Healthcare UK (No.5) Limited · Mar 18, 2026
Publication

Drug Adsorbed Highly Porous Activated Carbon For Enhanced Drug Delivery

EP3952841A1 · THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS · Mar 18, 2026
Publication

Isopropylcarbonate Benzoyl Peroxide Compositions And Methods Of Use

EP3946597A1 · Galderma Holding SA · Mar 18, 2026
Publication

Novel Compounds And Therapeutic Uses Thereof

EP3947417A1 · Centauri Therapeutics Limited · Mar 18, 2026
Publication

Compositions Comprising Deuterated Heterocyclic Gamma Carboline And Their Use In The Treatment Or Prophylaxis Of A Central Nervous System Disorder

EP3888656A1 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Companion Diagnosis Biomarker Composition And Companion Diagnosis Kit Containing Same

EP4060346A1 · Innobation Bio Co., Ltd. · Mar 18, 2026
Publication

Gene Delivery Systems For Treatment Of Heart Failure

EP4058584A1 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Anti Fungal Compositions And Methods For Using Same

EP4058066A1 · The Research Foundation for The State University of New York · Mar 18, 2026
Publication

Tyk2 Pseudokinase Ligands

EP4054581A1 · Ventyx Biosciences, Inc. · Mar 18, 2026
Publication

Charged Ion Channel Blockers And Methods For Use

EP4054559A1 · Nocion Therapeutics, Inc. · Mar 18, 2026
Publication

Cannabidiol Enhanced Probiotic Compositions And Uses Thereof For Treatment Of Infections

EP4041222A1 · Buzzelet Development And Technologies Ltd · Mar 18, 2026
Publication

Biomarker Based Treatment Of Focal Segmental Glomerulosclerosis And Diabetic Kidney Disease

EP4037680A1 · GFB (ABC), LLC · Mar 18, 2026
Publication

Phosphodiesterase Inhibitors And Use

EP4034094A1 · Zenshine Pharmaceuticals (Nanjing) Group Co., Ltd. · Mar 18, 2026
Publication

Treatment Of Egfr Mutant Related Cancers Using A Combination Of Egfr And Cdk4/6 Inhibitors

EP4034121A1 · Beta Pharma, Inc. · Mar 18, 2026
Publication

Agricultural And Horticultural Pesticide Having As Active Component Condensed Heterocyclic Compound Having Substituted Cyclopropane Oxadiazole Group Or Salt Thereof; Ectoparasite Or Endoparasite Control Agent For Animals; And Use Method Thereof

EP4029571A1 · Nihon Nohyaku Co., Ltd. · Mar 18, 2026
Publication

Anti Fibrotic Compounds And Use Thereof

EP4025559A1 · Hadasit Medical Research Services and Development Ltd. · Mar 18, 2026
Publication

Pentapeptide And Methods Of Use Thereof

EP4065171A1 · THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS · Mar 18, 2026
Publication

Pharmaceutically Active Pyrazolo Pyridone Modulators Of Dcn1/2 Mediated Cullin Neddylation

EP3986893A1 · University Of Kentucky Research Foundation · Mar 18, 2026
Publication

Pulrodemstat For Use In The Treatment Of Cancer By Targeting Cold Tumors

EP3983016A1 · Celgene Corporation · Mar 18, 2026
Publication

Synthesis Of Meldrum's Acid Derivatives For Use As Anti Uva And Anti Blue Light Agent

EP4061322A1 · Institut des Sciences et Industries du Vivant et de l'Environnement - AgroParisTech · Mar 18, 2026
Publication

Antibodies Targeting, And Other Modulators Of, The Cd276 Antigen, And Uses Thereof

EP4061841A1 · Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4081308A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Plasmid Combination And Application Thereof In Preparing Modified Immune Cells

EP4029944A1 · Juventas Co., Ltd. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076536A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Histone Deacytlase 6 Modulation Of Titin Protein Mediated Cardiac Tissue Stiffness And Method For Same

EP4069364A2 · The Regents of the University of Colorado, a body corporate · Mar 18, 2026
Publication

Compositions And Methods For Immunotherapy

EP4058035A1 · Ludwig Institute for Cancer Research Ltd · Mar 18, 2026
Publication

Anti Tnf Alpha Humanized Monoclonal Antibody Tcx060 Having Low Immunogenicity And Low Adcc/Cdc Function, And Use Thereof

EP3967708A1 · Abmax Biopharmaceuticals · Mar 18, 2026
Publication

Benzothiophene Compound, Preparation Method Therefor And Use Thereof

EP3964504A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Avapritinib For Use In The Treatment Of Eosinophilic Disorders

EP4041244A1 · Blueprint Medicines Corporation · Mar 18, 2026
Publication

Bromodomain Inhibitors

EP4051383A1 · Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen · Mar 18, 2026
Publication

Silicon Ion Complex Organized With Carboxylic Acid, Method For Manufacturing Complex, And Product Using Same

EP3960714A1 · Korea New Technology Co.,Ltd. · Mar 18, 2026
Publication

Flagellin Fusion Protein And Use Thereof

EP3960756A1 · Industry Foundation of Chonnam National University · Mar 18, 2026
Publication

Oligonucleotides Targeted To Pnpla3 For Use In A Method Of Treating A Liver Disease

EP4045062A1 · Astrazeneca AB · Mar 18, 2026
Publication

Plant Messenger Packs Encapsulating Polypeptides And Uses Thereof

EP3955896A1 · Flagship Pioneering Innovations VI, LLC · Mar 18, 2026
Publication

A Class Of Bifunctional Chimeric Heterocyclic Compounds For Targeted Degradation Of Androgen Receptors And Use Thereof

EP3957633A1 · Hinova Pharmaceuticals Inc. · Mar 18, 2026
Publication

A Method Of Altering A Differentiation Status Of A Cell

EP3953452A2 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Methods For Treatment Of Niemann Pick Disease Type C

EP3952859A1 · Loma Linda University · Mar 18, 2026
Publication

Prevention Of Stress Induced Fear And Depressive Like Behavior With Serotonin 4 Receptor Agonists

EP3952852A1 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Product For Therapy And Methods

EP4031653A1 · The University of Bristol · Mar 18, 2026
Publication

Stat Degraders And Uses Thereof

EP3946360A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Nonpeptide Somatostatin Type 5 Receptor Agonists And Uses Thereof

EP4013748A1 · Crinetics Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Heterocyclic Compound

EP4005637A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Transdermal Solvent System And Methods Of Use

EP3999032A1 · Donaghys Limited · Mar 18, 2026
Publication

Cannabinoid Conjugate Molecules

EP3986389A1 · Diverse Biotech, Inc. · Mar 18, 2026
Publication

Anti Cd73, Anti Pd L1 Antibodies And Chemotherapy For Treating Tumors

EP3947447A1 · Medimmune, LLC · Mar 18, 2026
Publication

Immune Cell Containing Tumor Antigen Recognition Receptor And Application Thereof

EP3964568A1 · Shanghai Pharmaceuticals Holding Co., Ltd. · Mar 18, 2026
Publication

Liquid Composition Comprising Antibody Of Human Interleukin 4 Receptor Alpha

EP3939609A1 · Connect Biopharma HongKong Limited · Mar 18, 2026
Publication

Method For Selecting Subject Likely Benefiting From Pharmaceutical Composition For Treating Or Preventing Cancer

EP3932491A1 · International Institute of Cancer Immunology, Inc. · Mar 18, 2026
Publication

Amniotic Fluid Derived Extracellular Vesicles And Uses Thereof For Wound Healing

EP3930734A1 · Merakris Therapeutics, LLC · Mar 18, 2026
Publication

Liquid Dressing Compositions Comprising Shellac And Metals For Veterinary Uses

EP4009988A1 · Cambridge Enterprise Limited · Mar 18, 2026
Publication

Liquid Dressing Compositions Comprising Shellac And Metals

EP4009987A1 · Cambridge Enterprise Limited · Mar 18, 2026
Publication

Method For Treating Cough By Using Diaminopyrimidine Compound

EP3960179A1 · Beijing Tide Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Compound For Treating Autoimmune Skin Diseases Caused By Inflammation, And Use Thereof

EP3964212A1 · Generos Biopharma Ltd. · Mar 18, 2026
Publication

Method For Treating Endometriosis Associated Pain By Using Diaminopyrimidine Compound

EP3960178A1 · Beijing Tide Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Antibody

EP3911683A1 · King's College London · Mar 18, 2026
Publication

Pyrazolylbenzene 1,3 Diols For Diseases Associated With G Protein Coupled Receptor 18 And In Combination With Transient Receptor Potential Vanilloid 1

EP3901142A1 · Consejo Superior de Investigaciones Científicas (CSIC) · Mar 18, 2026
Publication

Topical Aqueous Pharmaceutical Compositions Of Flurbiprofen And Chlorhexidine

EP3834815A1 · Sanovel Ilac Sanayi ve Ticaret A.S. · Mar 18, 2026
Publication

A Composition For The Delivery Of Biologically Active Agents And Uses Thereof

EP3946458A1 · Cytomatrix Limited · Mar 18, 2026
Publication

Methods For Treatment Of Subjects With Preexisting Immunity To Viral Transfer Vectors

EP3962537A1 · Cartesian Therapeutics, Inc. · Mar 18, 2026
Publication

Tumor Necrosis Factor (Tnf) Superfamily Receptor Binding Molecules And Uses Thereof

EP3750918A1 · IGM Biosciences, Inc. · Mar 18, 2026
Publication

Sustained Release Dosage Forms For A Jak1 Inhibitor

EP3721873A1 · Incyte Holdings Corporation · Mar 18, 2026
Publication

Method And Apparatus For Increasing Sperm Motility

EP3711818A1 · Nichia Corporation · Mar 18, 2026
Publication

Beta Glucan For Use In The Treatmane Of A Remission

EP3858362A1 · Pleuran, s.r.o. · Mar 18, 2026
Publication

Composition Comprising Non Viable Probiotic Bacteria And Its Use In Therapy

EP3682890A1 · Proge Farm S.r.l. · Mar 18, 2026
Publication

Oligonucleotides For Modulating Atxn2 Expression

EP3947677A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Food Supplement

EP3927183A1 · Microphyt · Mar 18, 2026
Publication

Composition Comprising A Combination Of A Protoporphyrin Ix (Ppix) Precursor Selected From Methyl Aminolevulinate (Mal) And Aminolevulinic Acid(ala), Ethylenediaminetetraacetic Acid (Edta) And Epigallocatechin Galate (Egcg) For Topical Use In Photodynamic Therapy

EP3970714A1 · Universidad De La Frontera · Mar 18, 2026
Publication

Substituted Indoles And Methods Of Use Thereof

EP3837240A1 · Epizyme, Inc. · Mar 18, 2026
Publication

Glycine Based Peptides For Use In The Treatment Of Non Alcoholic Fatty Liver Disease And Non Alcoholic Steatohepatitis

EP3833373A1 · Diapin Therapeutics LLC · Mar 18, 2026
Publication

Cellulose Based Topical Formulations

EP3833362A1 · YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD · Mar 18, 2026
Publication

Sustained Release Compositions Comprising A Therapeutic Agent For Treating Depression Or Anxiety And Uses Thereof

EP3829539A1 · Taiwan Liposome Company, Ltd. · Mar 18, 2026
Publication

Kif18 A Inhibitors

EP3897852A1 · Amgen Inc. · Mar 18, 2026
Publication

Novel P62 Ligand Compound, And Composition For Preventing, Alleviating, Or Treating Proteinopathies Comprising Same

EP3828163A1 · Autotac Inc. · Mar 18, 2026
Publication

Antitumor Antagonist Consisting Of A Mutated Tgfß1 Rii Extracellular Domain And An Immunoglobulin Scaffold

EP3990116A1 · Zelgen Holdings Limited · Mar 18, 2026
Publication

Methods Of Treating Schizophrenia And Other Neuropsychiatric Disorders

EP3894556A1 · University of Rochester · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3817822A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Hyaluronic Acid Hydrolyzing Enzyme Mutant And Pharmaceutical Composition Comprising Same

EP3636752A1 · Alteogen Inc. · Mar 18, 2026
Publication

C11 Cyclic Substituted 13 Membered Macrolides And Uses Thereof

EP3883945A1 · Zikani Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Ketogenic Compounds, Compositions, Methods And Use Thereof

EP3806906A1 · 9500-0535 Québec Inc. · Mar 18, 2026
Publication

Cannabinoid Composition And Methods Of Treatment Using The Same

EP3806845A1 · Cannpal Animal Therapeutics Limited · Mar 18, 2026
Publication

Methods For Expansion Of Natural Killer (Nk) Cell Subset And Related Compositions And Methods

EP3884041A2 · Indapta Therapeutics, Inc. · Mar 18, 2026
Publication

Liquid Formulation Containing Botulinum Toxin And Stabilizing Agent, And Preparation Method Therefor

EP3782605A1 · Hugel Inc. · Mar 18, 2026
Publication

Prodrugs Of Hiv Reverse Transcriptase Inhibitors

EP3785714A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Stable Pharmaceutical Composition And Methods Of Using Same

EP3797591A1 · Amarin Pharmaceuticals Ireland Limited · Mar 18, 2026
Publication

Use Of One Or A Combination Of Phytocannabinoids In The Treatment Of Epilepsy

EP3718603A1 · Jazz Pharmaceuticals Operations UK Limited · Mar 18, 2026
Publication

Antibodies Directed Against Staphylococcus Aureus Leukotoxins

EP3864040A1 · Medimmune, LLC · Mar 18, 2026
Publication

High Affinity Monoclonal Antibodies (Mabs) Against Cell Surface Expressed Human Carbonic Anhydrase Ix (Hca Ix), And Uses Thereof

EP3784700A1 · National Research Council of Canada · Mar 18, 2026
Publication

Mycobacterial Antigen Compositions And Methods Of Use

EP3784275A2 · Children's National Medical Center · Mar 18, 2026
Publication

Identification Of Granins As The Pathogenic Factor Of Alzheimer's Disease And Compositions And Methods For Inhibiting Granin Aggregation And Treating Alzheimer's Disease

EP3773547A1 · Yoo, Seung Hyun · Mar 18, 2026
Publication

Aqueous Oral Care Solutions, Methods, Kits, And Tooth Surfaces Having A Coating Derived From The Oral Care Solution

EP3843692A1 · Solventum Intellectual Properties Company · Mar 18, 2026
Publication

Anti Human Lag 3 Monoclonal Antibody And Use Thereof

EP3778632A1 · Jiangsu Huaiyu Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Methods And Compositions For Blocking Interaction Between Non Glycosylated Pd 1 Polypeptides

EP3773916A1 · TrueBinding, Inc. · Mar 18, 2026
Publication

Camptothecin Peptide Conjugates

EP3773736A1 · Seagen Inc. · Mar 18, 2026
Publication

Recombinant Protein Targeting Pd L1 And Vegf

EP3891182A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Dpep 1 Binding Agents And Methods Of Use

EP3887390A1 · Arch Biopartners, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP3886904A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Anti Pd L1/Anti 4 1 Bb Bispecific Antibodies And Uses Thereof

EP3891187A1 · ABL Bio Inc. · Mar 18, 2026
Publication

Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders

EP3887351A1 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Thiamine Compound, Preparation Method And Pharmaceutical Composition Thereof

EP3889160A1 · Shanghai Raising Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Methods And Compositions For Treating Or Preventing The Development Of Food Allergies

EP3876966A1 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Proto Antigen Presenting Synthetic Surfaces, Activated T Cells, And Uses Thereof

EP3867353A1 · Berkeley Lights, Inc. · Mar 18, 2026
Publication

Supar And Prediction And Treatment Of Acute Kidney Injury

EP3856244A1 · Reiser, Jochen · Mar 18, 2026
Publication

Suppressing Ige Mediated Allergy By Desensitization With Monovalent Anti Fc Epsilon Ri Alpha Monoclonal Antibody

EP3852804A1 · University of Cincinnati · Mar 18, 2026
Publication

Methods And Compositions Comprising Surfactant Protein D (Sp D)

EP3774875A1 · Airway Therapeutics, Inc. · Mar 18, 2026
Publication

Nanoparticle Compositions

EP3572072A1 · Anterios, Inc. · Mar 18, 2026
Publication

Long Lasting Effect Of New Botulinum Toxin Formulations

EP3845241A1 · Medy-Tox, Inc. · Mar 18, 2026
Publication

Combinations Of Relacorilant And A Radiolabelled Somatostatin Analogue For Use In Localising Neuroendocrine Tumours

EP3897629A1 · Corcept Therapeutics Incorporated · Mar 18, 2026
Publication

Fusion Protein Constructs For Complement Associated Disease

EP3893916A2 · Akebia Therapeutics, Inc. · Mar 18, 2026
Publication

Antimicrobial Compositions Comprising Modified Clay And Nonionic Triblock Copolymers

EP3897530A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Lactobacillus Paracasei Strain And Use Thereof

EP3792342A1 · Kobiolabs, Inc. · Mar 18, 2026
Publication

Completely Humanized Monoclonal Neutralizing Antibody For Tetanus Toxin And Application Thereof

EP3733699A1 · Zhuhai Trinomab Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Continuous Administration Of Vitamin B12 For The Treatment Of Cerebrovascular Disease Or Central Nerve Injury

EP3730144A1 · Osaka University · Mar 18, 2026
Publication

Method For Producing Cell Mass Including Pituitary Tissue, And Cell Mass Thereof

EP3715450A1 · Sumitomo Chemical Company, Limited · Mar 18, 2026
Publication

Dicycloplatin For Use In Treating And/Or Preventing Pain

EP3714881A1 · Medoncare Pharmaceutical Co., Ltd · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3684365A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Hepatitis B Antiviral Agents

EP3675637A1 · Enanta Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Novel Method For Producing Antibody Drug Conjugate

EP3677568A1 · Daiichi Sankyo Company, Limited · Mar 18, 2026
Publication

Oxidized Polysaccharides And Methods Of Use Thereof

EP3821880A1 · President and Fellows of Harvard College · Mar 18, 2026
Publication

N Cyano 7 Azanorbornane Derivatives And Uses Thereof

EP3837262A1 · Amgen Inc. · Mar 18, 2026
Publication

Combination Therapy For Treatment Of Leukemia

EP3740215A1 · City St George's, University of London · Mar 18, 2026
Publication

Ophthalmic Composition

EP3827818A1 · Zaklady Farmaceutyczne Polpharma S.A. · Mar 18, 2026
Publication

Drug Device Configured For Wireless Communication

EP3643355A1 · Pop Test Abuse Deterrent Technology LLC · Mar 18, 2026
Publication

Compounds And Methods For Treating An Epileptic Disorder

EP3636264A1 · The Regents of the University of California · Mar 18, 2026
Publication

Compositions And Methods For Inducing Conformational Changes In Cereblon And Other E3 Ubiquitin Ligases

EP3827836A1 · Celgene Corporation · Mar 18, 2026
Publication

Synthetic Nutritional Compositions Tailored For Infants Of Specific Ages, And Nutritional Systems Comprising Them

EP3727033A1 · Société des Produits Nestlé S.A. · Mar 18, 2026
Publication

Inhibition Of Autism Spectrum Disorder Using Ribosomal Read Through Compounds

EP3684346A1 · Friedrich Miescher Institute for Biomedical Research · Mar 18, 2026
Publication

Heterocyclic Compound

EP3661931A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Salts And Solid State Forms Of Plinabulin

EP3661927A1 · Assia Chemical Industries Ltd. · Mar 18, 2026
Publication

Doramapimod For Use In The Treatment Of Endotoxemia

EP3582781A1 · The University of Melbourne · Mar 18, 2026
Publication

Production Of Recombinant Vaccine Against Helminths In Pichia Pastoris

EP3572514A1 · Tendler, Miriam · Mar 18, 2026
Publication

Probenecid For Use In Treating Epileptic Diseases, Disorders Or Conditions

EP3651758A1 · Paris Sciences et Lettres · Mar 18, 2026
Publication

Methods Of Treating Brain Tumors Using Combination Therapy

EP3638245A1 · Les Laboratoires Servier · Mar 18, 2026
Publication

Compositions And Methods Related To Engineered Fc Constructs

EP3565588A1 · Momenta Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Hydroxynorketamine For The Use In The Treatment Of Depression

EP3641742A2 · Ketabon GmbH · Mar 18, 2026
Publication

A Process For The Preparation Of Polymorphic Form Of Robenacoxib

EP3830072A1 · KRKA, d.d., Novo mesto · Mar 18, 2026
Publication

Nitrogenated Heterocyclic Amide Compound, And Use Thereof For Medical Purposes

EP3747888A1 · Japan Tobacco Inc. · Mar 18, 2026
Publication

Lactobacillus Plantarum For Skin Care

EP3813859A1 · Symrise AG · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3737666A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Crbn Ligands And Uses Thereof

EP3737675A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Ophthalmic Composition Comprising Inorganic Copper Salt For The Treatment Of Myopic Progression

EP3735209A1 · University of Utah Research Foundation · Mar 18, 2026
Publication

Oxadiazoles As Agonists Of The Muscarinic M1 And/Or M4 Receptor

EP3810607A1 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Use Of ß Glucan Extract In Immunopotentiation Of An Avian Animal

EP3787677A1 · Lesaffre et Compagnie · Mar 18, 2026
Publication

Methods For Isolating Tumor Specific Immune Cells From A Subject For Adoptive Cell Therapy And Cancer Vaccines

EP3624774A1 · Crititech, Inc. · Mar 18, 2026
Publication

Pharmaceutical Compositions For Prevention And/Or Treatment Of Infections

EP3784223A1 · European Molecular Biology Laboratory · Mar 18, 2026
Publication

Her2 Targeting Molecules Comprising De Immunized, Shiga Toxin A Subunit Scaffolds

EP3573652A1 · Molecular Templates, Inc. · Mar 18, 2026
Publication

Tick Vaccine

EP3781198A1 · Technische Universität Braunschweig · Mar 18, 2026
Publication

Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator

EP3774825A1 · Vertex Pharmaceuticals Incorporated · Mar 18, 2026
Publication

The Use Of Sgc Activators And Sgc Stimulators For The Treatment Of Cognitive Impairment

EP3787610A1 · Bayer Aktiengesellschaft · Mar 18, 2026
Publication

Compositions For Prolonging The Survival After Orthopic And Heteropic Xenogeneic Heart, Kidney, Lung Or Liver Transplantations

EP3773570A2 · Reichart, Bruno · Mar 18, 2026
Publication

Compounds For The Treatment Of Kinase Dependent Disorders

EP3743417A1 · Exelixis, Inc. · Mar 18, 2026
Publication

Attenuation System And Use Thereof

EP3795684A1 · CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. · Mar 18, 2026
Publication

Acute And Chronic Mitochondrial Electron Transport Chain Dysfunction Treatments And Graphenic Materials For Use Thereof

EP3615077A1 · William Marsh Rice University · Mar 18, 2026
Publication

Antisense Targeting Dynamin 2 And Use For The Treatment Of Centronuclear Myopathies And Neuropathies

EP3610016A1 · Genethon · Mar 18, 2026
Publication

Multi Arm Polymer Conjugates Of Tlr Agonist Compounds And Related Immunotherapeutic Treatment Methods

EP3568162A1 · Nektar Therapeutics · Mar 18, 2026
Publication

Composition For The Treatment Of Gastrointestinal Disorders

EP3570877A1 · Neilos S.r.l. · Mar 18, 2026
Publication

Organic Compositions To Treat Beta Enac Related Diseases

EP3431604A1 · Arrowhead Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Anti Cd40 Antibodies For Use In Prevention Of Graft Rejection

EP3774913A1 · Novartis AG · Mar 18, 2026
Publication

C5 Ar Inhibitors For Use In The Treatment Of Chemotherapy Induced Iatrogenic Pain

EP3723744A2 · Dompé farmaceutici S.p.A. · Mar 18, 2026
Publication

Uses And Methods For Il 2 Superagonists, Agonists, And Fusions Thereof

EP3641814A1 · Medicenna Therapeutics Inc. · Mar 18, 2026
Publication

Dosage Regimen Of Vidofludimus For Use In The Treatment Of Chronic Inflammatory And/Or Autoimmune Diseases

EP3713554A1 · Immunic AG · Mar 18, 2026
Publication

Anti Cldn 5 Antibody, And Drug Containing Said Antibody

EP3623384A1 · Osaka University · Mar 18, 2026
Publication

Lipophenolic Compounds For Use In The Treatment Of Viral Infections Disease And Central Nervous System Disorders.

EP3706732A1 · Université de Montpellier · Mar 18, 2026
Publication

Igf 1 R Monoclonal Antibodies And Uses Thereof

EP3638320A2 · Centre for Probe Development and Commercialization · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising Attenuated Streptococcus Pneumoniae Strains And Use Thereof

EP3616715A1 · Ildong Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

New Treatment Of Sma

EP3691647A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Combination Therapies With Ehmt2 Inhibitors

EP3612181A1 · Epizyme, Inc. · Mar 18, 2026
Publication

Anti Pd L1 Antibody And Use Thereof

EP3612565A1 · R-Pharm Overseas, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Pain Disorders

EP3610019A2 · Mansell, John · Mar 18, 2026
Publication

Biologic For The Treatment Of Cancer

EP3606548A2 · Loma Linda University · Mar 18, 2026
Publication

Extract Of Vegetation Waters For Use In Treating Damage To The Cardiovascular System

EP3684392A1 · Fattoria La Vialla Di Gianni, Antonio E Bandino Lo Franco - Societa' Agricola Semplice · Mar 18, 2026
Publication

Therapeutically Triggering An Innate Immune Response In A Target Tissue

EP3448397A1 · Qu Biologics Inc. · Mar 18, 2026
Publication

Method Of Treating Or Preventing Liver Conditions

EP3445450A1 · CSL Limited · Mar 18, 2026
Publication

Anti Human Vista Antibodies And Use Thereof

EP3442579A2 · Immunext, Inc. · Mar 18, 2026
Publication

High Affinity B7 H6 Antibodies And Antibody Fragments

EP3442576A1 · Trustees of Dartmouth College · Mar 18, 2026
Publication

Methods Of Treatment Using Chlorotoxin Conjugates

EP3442996A2 · Blaze Bioscience, Inc. · Mar 18, 2026
Publication

Compositions And Methods Related To Polycytotoxic T Cells

EP3439688A1 · The Regents of the University of California · Mar 18, 2026
Publication

Neuroactive Steroids, Compositions, And Uses Thereof

EP3426257A1 · Sage Therapeutics, Inc. · Mar 18, 2026
Publication

Microglia Derived From Pluripotent Stem Cells And Methods Of Making And Using The Same

EP3423564A1 · New York Stem Cell Foundation, Inc. · Mar 18, 2026
Publication

Anti Il1 Rap Antibodies And Antibody Drug Conjugates

EP3638697A1 · Bluefin Biomedicine, Inc. · Mar 18, 2026
Publication

Treatment Of Cutaneous Disorders

EP3634370A1 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Modulators Of The Integrated Stress Pathway

EP3704115A1 · Calico Life Sciences LLC · Mar 18, 2026
Publication

Agent For Preventing Or Treating Brain Atrophy

EP3632431A1 · FUJIFILM Toyama Chemical Co., Ltd. · Mar 18, 2026
Publication

Methods Of Treating High Risk Multiple Myeloma

EP3703749A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

C Terminal Cdnf And Manf Fragments, Pharmaceutical Compositions Comprising Same And Uses Thereof

EP3619227A1 · MyNeuroCure Oy · Mar 18, 2026
Publication

Improved T Cell Compositions And Methods

EP3612275A1 · Allogene Therapeutics, Inc. · Mar 18, 2026
Publication

Pectin Microcapsules, Method For The Manufacture And Use Thereof

EP3609477A1 · Université de Bourgogne · Mar 18, 2026
Publication

Amhrii Binding Compounds For Preventing Or Treating Lung Cancers

EP3609919A1 · Exelixis, Inc. · Mar 18, 2026
Publication

(+) Alpha Dihydrotetrabenazine For Use In The Treatment A Movement Disorder

EP3606529A1 · Adeptio Pharmaceuticals Limited · Mar 18, 2026
Publication

Small Molecule Dcn1 Inhibitors And Therapeutic Methods Using The Same

EP3601245A1 · The Regents of The University of Michigan · Mar 18, 2026
Publication

Donepezil Transdermal Delivery System

EP3490558A1 · Corium, LLC · Mar 18, 2026
Publication

Dry Powder Formulations And Methods For Treating Pulmonary Diseases

EP3184099A1 · Pulmatrix Operating Company, Inc. · Mar 18, 2026
Publication

Non Peptidic Gapdh Aggregation Inhibitor

EP3305762A1 · Osaka Prefecture University Public Corporation · Mar 18, 2026
Publication

Nutritional Compositions Comprising Lactobacillus Rhamnosus Gg, As Well As Dietary Butyrate And/Or A Compound For Stimulating Formation Of Endogenous Butyrate

EP3373747A1 · MJN U.S. Holdings LLC · Mar 18, 2026
Publication

Use Of Oligosaccharide Compositions To Enhance Weight Gain

EP3288389A1 · Children's Hospital Medical Center · Mar 18, 2026
Publication

Platelet Like Proteo Microparticles And Method Of Using Such In Drug Delivery

EP3285742A1 · Academia Sinica · Mar 18, 2026
Publication

Anti Human Cd19 Antibodies With High Affinity

EP3356405A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising Valsartan And Sacubitril For Use In The Treatment Of A Disorder Or Disease In A Specific Patient Group

EP3355880A1 · Novartis AG · Mar 18, 2026
Publication

Nicotine For Use In Reducing Frequency Of Falls In Subjects With Parkinson's Disease

EP3727043A1 · Golden Gait Biotech, S.L. · Mar 18, 2026
Publication

Poziotinib Against Cancer Cells Bearing Egfr Or Her2 Exon 20 Mutations

EP3541832A1 · Board of Regents, The University of Texas System · Mar 18, 2026
Publication

2,4 Dspbn For Use In A Method Of Treatment Of Cochlear Synaptopathy Or Vestibular Synaptopathy By Enhancing Synaptogenesis And Neuritogenesis

EP3532042A1 · Hough Ear Institute · Mar 18, 2026
Publication

Compounds And Uses Thereof

EP3529245A1 · Janssen Pharmaceutica NV · Mar 18, 2026
Publication

Magnesium Picolinate Compositions And Methods Of Use

EP3525770A1 · Bonafide Health, LLC · Mar 18, 2026
Publication

Heterodimeric Immunoglobulin Constructs And Preparation Methods Thereof

EP3504234A1 · Beijing Hanmi Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Cyclic Compound

EP3511320A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Inhibitors Of Cytochrome P450 Family 7 Subfamily B Member 1 (Cyp7 B1) For Use In Treating Diseases

EP3558304A2 · Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · Mar 18, 2026
Publication

Ebola Virus Antibodies And Binding Agents Derived Therefrom

EP3487521A2 · Emory University · Mar 18, 2026
Publication

Compositions Comprising Low Impact Ampakines For Treating Attention Deficit Disorders

EP3436021A1 · RespireRx Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives

EP3233865A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Methods And Compositions Particularly For Treatment Of Attention Deficit Disorder

EP3212172A1 · Purdue Pharma · Mar 18, 2026
Publication

Modified Antimir 138 Oligonucleotides

EP3177722A1 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Chimeric Antigen Receptors (Car) For Use In Therapy And Methods For Making The Same

EP3134437A1 · Board of Regents, The University of Texas System · Mar 18, 2026
Publication

Protein Aqueous Suspension

EP3064213A1 · Terumo Kabushiki Kaisha · Mar 18, 2026
Publication

7 A Heterocycle Substituted 6, 6 Difluoro Bicyclic Himbacine Derivatives

EP3035930A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Anti Zika Virus Antibodies And Methods Of Use

EP3484917A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Bacteria Based Gel Compositions For Topical Applications And Uses Thereof

EP3463291A1 · Probiotical S.p.A. · Mar 18, 2026
Publication

Crystalline Form 4 Of 4 (5 (4,7 Dimethylbenzofuran 2 Yl) 1,2,4 Oxadiazol 3 Yl)benzoic Acid, A Processes For Its Preparation And Uses Thereof

EP3475274A1 · King's College London · Mar 18, 2026
Publication

Polynucleotides Encoding Citrin For The Treatment Of Citrullinemia Type 2

EP3458081A1 · ModernaTX, Inc. · Mar 18, 2026
Publication

Crystalline Forms Of N [2 (3 Hydroxy 3 Methylbutyl) 6 (2 Hydroxypropan 2 Yl) 2 H Indazol 5 Yl] 6 (Trifluoromethyl)pyridine 2 Carboxamide

EP3448847A1 · Bayer Pharma Aktiengesellschaft · Mar 18, 2026
Publication

Solid State Forms Of Venetoclax And Processes For Preparation Of Venetoclax

EP3426655A1 · Assia Chemical Industries Ltd. · Mar 18, 2026
Publication

Unit Structure Type Pharmaceutical Composition For Nucleic Acid Delivery

EP2842546A1 · The University of Tokyo · Mar 18, 2026
Publication

Optimised Subcutaneous Therapeutic Agents

EP2838566A2 · Cantab Biopharmaceuticals Patents Limited · Mar 18, 2026
Publication

Bispecific Antibodies Against Her2 And Cd3

EP2699262A2 · Genmab A/S · Mar 18, 2026
Publication

Generation Of Neural Stem Cells From Human Trophoblast Stem Cells

EP2640403A2 · Accelerated BioSciences Corp. · Mar 18, 2026
Publication

Antiviral And Retroviral Composition, In Particular For Treating Aids

EP2456452A1 · Commin, Alix Roland · Mar 18, 2026